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Continuous measurements of health outcome data are often dichotomized into
binary ( i.e. positive/negative) data for diagnosis and subsequent statistical anal-
ysis. The disadvantages of dichotomizing continuous data for statistical inference
are well established in the literature, yet this practice is commonplace in health
research.
In this thesis, we investigate the impact of dichotomization of data when the aim
of analysis is to determine disease prevalence and risk, and propose solutions to
some of the main challenges introduced by dichotomization in the context of global
heath research.
First, using model-based geostatistics, we show how dichotomization reduces the
predictive performance of geostatistical models through loss of information and
by reducing the reliability of parameter estimates. We demonstrate this using a
simulation study, as well as mapping prevalence and risk of anaemia in Ethiopia,
and stunting in Ghana.
We then explore the limitations dichotomization introduces to estimation of malaria
transmission in serology models, and propose a novel flexible and unified modelling
framework which uses continuous antibody measurements instead of dichotomized
data to estimate transmission intensity. Using Western Kenya, we demonstrate
the properties of this new approach.
Finally, we address the use of thresholds for dichotomization of continuous anti-
body measurements when the goal is to estimate malaria seroprevalence. We utilize
the principles of the unified modelling framework to develop a threshold-free ap-
proach to estimating seroprevalence. Using the same Western Kenyan data-set,
we show how this new approach improves model fit and provides more consistent
estimates than traditional methods.
Together, these investigations demonstrate the significant impact dichotomization
of continuous data has on statistical inference across different areas of health re-
search, and that this practice should be avoided where possible.
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Across the world, data on health outcomes are routinely collected for monitoring
and surveillance of disease prevalence and risk. In the global south, for example,
data are collected on a variety of disease indicators for malaria, anaemia, diarrhoeal
diseases, HIV/AIDS, and Neglected Tropical Diseases (NTDs), among others.
There are a variety of ways these data can be managed and analysed in order to
make statistical inference on disease prevalence and risk, as well as monitor how
these parameters change over time. A key goal of analysis is to make informed
data-driven decisions on intervention strategy and health policy.
In this thesis we explore research questions around improving the estimation and
prediction of disease prevalence and risk, with a focus on applications in the global
south. Specifically, we challenge the common practice of dichotomizing continuous
health outcome data into binary data, i.e. positive/negative data, for statistical
inference.
First, we explore how dichotomization affects the performance of geostatistical
models in mapping disease prevalence and risk, using anaemia and stunting data.
We then address dichotomization in the analysis of malaria serology data, and
present a novel modelling framework which uses continuous antibody measure-
ments, rather than dichotomized data, to estimate malaria transmission intensity.




1.1 Model-Based Geostatistics and mapping dis-
ease prevalence
Maps are important tools in the understanding and visualization of infectious dis-
ease prevalence and risk on a spatial scale. Specifically, for infectious diseases
where location of individuals is correlated to disease, maps underpin monitor-
ing and surveillance of these diseases, and often provide an evidence base for the
design and implementation of prevention and control programs. Model-based Geo-
statistics (MBG) is a branch of spatial statistics which allow us to model spatial
variation in disease prevalence, taking into account various sources of uncertainty.
1.1.1 The standard geostatistical model for mapping disease preva-
lence
Let Yi be the number of individuals who test positive for a disease of interest out of
a total number of mi individuals (i.e. m is the sample size), sampled at locations
xi : i = 1, ...n (with n being the total number of locations), which represent distinct
geographical coordinates of sampled villages or households.
The standard geostatistical model for this data is a generalized linear model with a
binomial distribution, logistic link function, and a linear predictor [1, 2]. The lin-
ear predictor consists of explanatory variables and an additional Gaussian spatial
random process S = S(x) : x ∈ R2 on which prevalence is statistically dependent.
If p(x) represents the prevalence at location x, the sampling distribution of the
resulting data is denoted as Yi|S(xi),mi, p(xi) ∼ Bin(mi, p(xi)) for i = 1, ...n. The






= α + βTd(xi) + S(xi) + Zi (1.1)
where d(xi) is a vector of location-specific covariates such as social economic sta-
tus and interventions at household level, and β is the corresponding vector of
regression coefficients for these covariates. S(xi) is a spatial random effect used
to account for spatial correlation between observations, while Zi is the ‘nugget
effect’ or ‘noise’. The nugget effect represents the unstructured residual variation
which can either be small-range spatial variation, or within-household variations
like genetic variation of individuals. The goal of most geostatistical analysis is to
predict S at an unobserved location x.
We model S(x) as a stationary and isotropic Gaussian process with mean zero,
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variance σ2, and an exponentially decaying correlation function expressed as
ρ(u) = e−u/φ (1.2)
where u is the Euclidean distance between points x and x′, and φ is the scale of
spatial correlation.
The model in (1.1) can be expanded to include individual level information such
that the outcome variable Yi becomes Yij representing the outcome for the j−th
individual in the i−th household. The sampling model for the resulting data is
then denoted as Yij ∼ Bernoulli(pij) where pij is the probability of a positive test
for the individual i in household j. The link for pij, at different locations of x in






= α + βTd(xi) + γT eij + S(xi) + Zij (1.3)
where we distinguish between covariates, d(xi), that express properties of the lo-
cations and covariates, eij, for individual traits e.g. age and gender.
1.1.2 Dichotomization of data in geostatistical inference
The standard geostatistical model is based on binary (ie. positive/negative) dis-
ease outcome data. Equation (1.1) takes aggregated binary data, while (1.3) takes
individual-level binary data at a location x. This reflects the reality that in prac-
tice, continuous health outcome data are often dichotomized into binary data for
diagnosis and subsequent statistical analysis. The disadvantages of this approach
include loss of information, which impacts the ability to reliably recover regression
relationships, and reduces the precision of parameter estimates, [3–10]. Despite
these drawbacks, dichotomization of data is common practice in health research.
In the first paper (chapter 2), we investigate how the dichotomization of continu-
ous outcomes affects the performance of geostatistical models both in parameter
estimation and prediction of disease risk. To address this question, we carry out
a comparative analysis between geostatistical models where the outcome variable
is continuous, versus models where the derived binary outcome is analysed.
We compare two possible approaches for disease mapping: the first defines a geo-
statistical model for a continuous measurement, and uses this to map disease
prevalence and predict the probability of exceeding a threshold relevant to public
health policy. The second approach first dichotomizes the continuous measure-
ment, based on a diagnostic threshold, into a binary outcome, and then develops
a geostatistical logistic regression based on this binary outcome.
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The specific research questions we address are: 1) how does spatial correlation
affect the loss of information and estimation of regression relationships, 2) can
dichotomization lead to substantially different and more uncertain spatial predic-
tions in disease prevalence, and 3) how can we use linear geostatistical models to
map disease prevalence and thus avoid the drawbacks of dichotomization?
1.2 Models for analysing malaria serology data
In the second paper (chapters 3), we address the use of dichotomization in the
analysis of malaria serology data. Serology (i.e. antibody) data are an increas-
ingly important tool in malaria surveillance. Current models for analysing malaria
serology data are limited by the need to dichotomize continuous antibody mea-
surements, as well as strict assumptions about malaria transmission dynamics. In
this paper, we propose a novel unified modelling framework that eliminates the
need for dichotomization, and combines existing models while addressing their lim-
itations. We also propose an alternative empirical approach to analysing malaria
serology data which relies entirely on the data, rather than biological assumptions
inherent to existing models.
1.2.1 The role of antibodies in protection against clinical malaria
Malaria is a mosquito-borne disease caused by Plasmodium parasites, and carried
by infected Anopheles mosquitoes. The majority of malaria cases worldwide are
attributed to the Plasmodium falciparum, (Pf ) species, however there are regional
variations in the prevalence of Plasmodium species including P.vivax P.malariae,
P.ovale and P.knowlesi [11, 12].
Once in the human host, the malaria parasites undergo several transformations and
migrations as part of their life cycle [13, 14]. Clinical manifestations of malaria
occur during the blood stage of the parasites, and antibodies which target blood
stage malaria parasites are important in the development of immunity to the dis-
ease. These antibodies occur in a broad range of specificities, and their functions
include blocking important parasite processes such as adhesion to and invasion of
cells, as well as cooperation with immune cells to tag and clear the parasites [14,
15].
In general, antibody responses to malaria antigens are characterised by the fol-
lowing properties: a) they confer ‘non-sterile’ immunity (i.e. incomplete protec-
tion), such that despite the presence of antimalarial antibodies, individuals remain
susceptible to re-infections, b) antibody levels are boosted upon re-infection, c)
in malaria endemic settings, antibody levels generally increase with age, and d)
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malaria antibodies decay in the absence of re-infection [14, 16–20].
1.2.2 The role of antibodies in malaria surveillance
Traditional methods of measuring malaria transmission rely on the detection of
the Plasmodium parasite in humans and mosquito populations. Parasite preva-
lence (PrP) is determined by the proportion of infected individuals at time of
data collection [20, 21], while the gold-standard measurement of transmission, the
entomological inoculation rate (EIR), is determined by the frequency at which
individuals are bitten by infectious mosquitoes [22]. Both of these measures are
affected by several factors, including: a) seasonal variations in transmission, b) low
densities of parasites in both humans and mosquitoes which result in low proba-
bility of sampling infected people and mosquitoes particularly in low transmission
areas, and c) deriving EIR, is labour-intensive and expensive [20–25].
Antibodies provide an alternative approach to measuring transmission intensity.
Because antibodies persist after infection, they: a) provide information on cumu-
lative exposure to malaria parasites over time, b) are more resistant to the effects
of seasonality in transmission, and c) allow estimation of transmission intensity
with more feasible sample sizes even in low transmission settings [21, 25–29].
1.2.3 Analysing malaria antibody data
Based on the profile of malaria antibodies described in section 1.2.1, three types
of models for the analysis of malaria serology data have been proposed so far:
Reversible catalytic models (RCMs), Antibody Acquisition Models (AAMs), and
the Antibody Density Model (ADM).
These models provide different measures of transmission intensity. In the RCM,
transmission is defined as the rate at which individuals convert from seronegative
to seropositive upon exposure to malaria parasites; in the AAM, transmission
intensity is defined as the rate at which antibodies are boosted upon exposure
to parasites; while in the AAM, transmission intensity is defined as the rate of
exposure to an infectious mosquito bite.
Reversible catalytic models (RCMs)
RCMs, are most commonly used. These models rely on first dichotomizing contin-
uous antibody measurements in order to define seropositive (S+) or seronegative
(S−) status. Following dichotomization, the resulting S+ and S− outcomes are
modelled using the RCM, which operates under the assumption that individuals
are born S−, they can ‘seroconvert’ to S+ upon exposure to malaria, and in the
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absence of exposure, ‘serorevert’ to S−. The seroconversion rate (λ) is related to
underlying transmission intensity while the seroreversion rate (ω) represents an-
tibody decay in the absence of malaria infection [20, 25, 26, 30–32]. Figure 1.1
illustrates this mechanistic model.
Figure 1.1: A representation of the reversible catalytic model (RCM) where
individuals transition between seronegative (S−) and seropositive (S+) states through
the seroconversion rate, λ(a) and the seroreversion rate, ω
.
Dichotomization in the RCM requires thresholds to define S+ status. These thresh-
olds are usually estimated using 1) a negative control group, which usually consists
of serum form non-exposed individuals (e.g. Europeans who never travelled to en-
demic areas) [25, 33], or 2) a mixture model which assumes a latent bi-modal
distribution of S− and S+ populations in the study sample itself [20]. The former
method is less prevalent due to potential underlying differences between immune
responses in these individuals and those living in endemic countries [21].
For the finite mixture model, assuming independent and identically distributed





(1− p)fS−(yi;µS− , σ2S−) + pfS+(yi;µS+ , σ2S+)
]
(1.4)
where fS+ is a univariate log-Gaussian distribution with mean µS+ and variance
σ2S+ for the S+ population, and analogously for S−; finally, p is the probability of
being S+. By using the point estimates of the mean, µ̂S− and standard deviation,
σS−, of the seronegative distribution S−, the seropositive threshold is often set
to µ̂S− + 3σS− [20, 32, 34, 35], while some studies have used µ̂S− + 2σS− and
µ̂S−+5σS− [36–39]. Alternatively, thresholds can be defined based on the predictive
probability of being S+ resulting from the fitted mixture distribution [20]. After
classification, the S+ and S− outcome variable is input for the RCM.
Let λ(a) denote the seroconversion rate for an individual at age a and ω the
seroreversion rate. According to the RCM, the temporal dynamics that regulate




= λ(a)(1− p(a))− ωp(a). (1.5)
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Three transmission profiles are often proposed to model λ(a): constant transmis-
sion; a sharp stepwise drop in transmission which may occur when transmission
is suddenly interrupted due to, say, the introduction of an intervention; and a
linear drop in transmission when the reduction is more gradual [20, 30, 32, 40, 41].
These are strong assumptions on the temporal dynamics of transmission, and their
validity is often questionable. Additionally, RCMs do not sufficiently account for
antibody boosting due to repeated exposure to malaria parasites. A more recent
study by Varela et al. [42] proposes an extension to the RCM where the number
of times that λ changed in the past, is also estimated from the data.
In order to circumvent the problem of dichotomization, and account for antibody
boosting, the AAM, and the ADM have been proposed.
Antibody Acquisition Models (AAMs)
The AAM, rather than the dichotomize the data, makes use of the full continuous
antibody measurement to obtain an alternative measure of transmission [20, 30,
31, 40]. The AAM relies on the assumption that the boosting rate (γ), i.e the
rate at which antibodies are acquired upon exposure to parasites, can be used as
a proxy for the underlying transmission intensity, and in the absence of exposure,
antibodies decay at rate r. These dynamics are illustrated in figure 1.2.
Figure 1.2: A representation of the antibody acquisition model (AAM) where
antibody levels are boosted at rate γ(a) upon exposure, and decay at rate r in the
absence of exposure.
Assuming that antibody levels of individuals at age a follow a log-Gaussian dis-
tribution with mean µ(a) and variance σ2 [20, 30, 40], let µ(a) denote the average
antibody values (on the log scale) in the general population of individuals of age a.
According to the AAM, the temporal dyamics that regulate µ(a) can be expressed
by the following differential equation
dµ
da
= γ(a)− rµ(a). (1.6)
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This equation can be used to infer changes in average antibody levels as a function
of age a. γ(a) is often modelled according to the same three transmission profiles
described for λ(a) in the RCM.
Antibody Density Model (ADM)
Similar to the AAM, the ADM makes use of antibody boosting to derive a mea-
sure of transmission intensity [21]. The model assumes that the rate at which
an individual is bitten by an infectious mosquito, λ̃, induces an antibody boost
in the individual, and that in the absence of exposure, antibody levels decay at
rate ρ̃. Implementation of this model requires discretizing the antibody antibody
measurements into compartments where individuals antibodies are boosted or de-
cay. In this framework, individuals move into higher antibody compartments at
rate λ̃ as their antibodies are boosted by exposure to parasites, and inversely, they
move into lower antibody compartments at rate ρ̃ as their antibodies decay in the
absence of exposure. In the ADM, λ̃ is the measure of underlying transmission
intensity. Let yi denote compartment i, with width ∆, where 1 ≤ i ≤ N and N
is the total number of compartments. According to the ADM, the proportion k,



















where h, i, j index the antibody compartments. The dynamics described in this
equation are illustrated in figure 1.3.
The RCM, AAM and ADM have strengths and limitations which are summarised
in table 1.1. In the second paper (chapter 3) of this thesis, we address many of
these limitations and propose a novel unified mechanistic model which combines
the properties of the RCM, mixture model and AAM. This novel framework also
provides additional flexibility in how we estimate malaria transmission intensity.
The key features of this new framework are 1) the use of continuous antibody
measurements, rather than dichotomized data 2) age-dependency of the antibody
levels and mixture distribution is accounted for, 3) assumptions around malaria
transmission profiles are relaxed, 3) added flexibility through linear regression, and
4) joint estimation of the transmission parameters λ(a) and γ(a).
Furthermore, as an alternative to the unified mechanistic model, we also present
an alternative empirical approach to modelling serology data where analysis is
based entirely on the data, rather than biological assumptions inherent to existing
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Figure 1.3: A representation of the antibody density model (ADM) where individuals
transition between antibody level compartments of width ∆. The transitions are driven
by the rate of exposure λ̃, which induces a boost of antibodies to higher compartments,
as well as antibody decay ρ, which reverts individuals to lower compartments.
models. The empirical model can be used to validate the assumptions of the unified
mechanistic model.
Finally, in the third paper (chapter 4), we use the empirical model introduced in the
second paper to develop a threshold-free approach for estimating seroprevalence.
While the goal of the RCM, AAM and ADM is to investigate historical changes
in transmission intensity, seroprevalence itself is a useful metric as it provides
as snap-shot of malaria exposure detected at a specific time point and location.
As previously described, in order to estimate seroprevalence, individuals are first
classified as S− or S+ based on a suitable threshold. However, the choice of the
threshold is arbitrary, and the same threshold is used across all data, ignoring age
dependency of antibody levels.
Therefore, we present a threshold-free approach to estimating seroprevalence which
1) accounts for age dependency of antibody levels and the mixture distribution, 2)
eliminates the need for a threshold, and 3) propagates the uncertainty in the sero-
prevalence estimate. We demonstrate how to propagate the uncertainty around
these seroprevalence estimates in further analysis, using the RCM as an example.
Note that in this new approach individuals are assigned ‘seropositive’ or ‘seronega-
tive’ based on both their antibody level for their age, whereas in classical analysis,
this classification is based solely on the individual’s antibody level.
The malaria serology models proposed in this thesis aim to provide a more statisti-
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Table 1.1: Summary of strengths and limitations of current malaria serology models
Model
RCM AAM ADM
Parameters seroconversion rate (λ) boosting rate (γ) exposure rate (λ̃)seroreversion rate (ρ) decay rate (r) decay rate (ρ̃)
Strengths
· effective in low transmission
settings where seropositivity
correlates to exposure
· Uses full continuous anti-
body measurement
· Accounts for boosting due to
re-exposure
· Data from multiple antigens
can be combined
· Accounts for boosting due to
re-exposure
· Better precision in estima-
tion of parameters than the
RCM
· effective even in high trans-
mission settings
· Better precision in estima-
tion of parameters than the
RCM
Limitations
· The need to dichotomize
continuous antibody measure-
ments
· Strong assumptions around
the temporal dynamics of
transmission
· The need to discretize con-
tinuous antibody data
· Strong assumptions around
the temporal dynamics of
transmission
· Assumes log normal distribu-
tion
· Computationally intensive
· Difficulty in accounting for
boosting due to re-exposure
· Not effective in high trans-
mission areas where many in-
dividuals are seropositive
cally sound likelihood-based approach to analysing malaria serology data without
the use of thresholds. These models assume a mixture distribution of antibody
data - however, in cases where the antibody distribution is not a mixture, or where
there is poor separation between the components of the mixture, the utility of these
models may be limited.
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Summary
Diagnosis is often based on the exceedance or not of continuous health
indicators of a predefined cut-off value, so as to classify patients into pos-
itives and negatives for the disease under investigation. In this paper, we
investigate the effects of dichotomization of spatially-referenced continuous
outcome variables on geostatistical inference. Although this issue has been
extensively studied in other fields, dichotomization is still a common prac-
tice in epidemiological studies. Furthermore, the effects of this practice in
the context of prevalence mapping have not been fully understood. Here, we
demonstrate how spatial correlation affects the loss of information due to di-
chotomization, how linear geostatistical models can be used to map disease
prevalence and thus avoid dichotomization, and finally, how dichotomization
affects our predictive inference on prevalence. To pursue these objectives,
we develop a metric, based on the composite likelihood, which can be used
to quantify the potential loss of information after dichotomization without
requiring the fitting of Binomial geostatistical models. Through a simula-
tion study and two applications on disease mapping in Africa, we show that,
as thresholds used for dichotomization move further away from the mean of
the underlying process, the performance of binomial geostatistical models
deteriorates substantially. We also find that dichotomization can lead to the
loss of fine scale features of disease prevalence and increased uncertainty in
the parameter estimates, especially in the presence of a large noise to signal
ratio. These findings strongly support the conclusions from previous studies
that dichotomization should be always avoided whenever feasible.
Keywords: binary data; dichotomization; disease mapping; linear geosta-
tistical model; model-based geostatistics; prevalence.
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2.1 Introduction
Continuous measurements of disease indicators - e.g. concentration of antibodies
in a blood sample - are used in many branches of health research to aid diagnosis
and treatment of patients, as well as monitoring and surveillance of diseases in
populations. Diagnosis is often based on the exceedance or not of a cut-off value
by the continuous indicator, to identify positives and negatives for the disease of
interest [43]. In some cases, for instance in anaemia epidemiology, multiple cut-offs
are also used to further categorize patients into groups, such as mild, moderate
and severe [44]. The rationale for such groupings is to aid and simplify both
interpretation and presentation of the results [5, 6, 45], while in clinical settings
the groupings are used for targeted treatment. As a result, statistical analysis is
often carried out on the categorical outcome obtained through the discretization
of the continuous measurement.
The disadvantages and loss of information yielded by this practice have been in-
vestigated in several studies. Fedorov et al. [3] showed that dichotomization of
continuous outcome variables can lead to a loss of 36% in terms of the Fisher’s
information for the population average. As a result of this, the statistical power
required to estimate regression relationships between a health outcome and risk
factors is also diminished [4]. Furthermore, in cases where the relationship is non-
linear or non-monotonic, dichotomization or categorization into few classes may
make that undetectable [5, 6]. All these issues are further exacerbated when the
choice of specific cut-offs is inconsistent or, in some cases, even arbitrary [7–9].
For example, cut-offs may vary within and across studies due to differences in the
sample populations from which they are derived or due to changes in how they are
defined according to clinical practice and operational policy.
In this paper, we investigate the effects of dichotomization of spatially-referenced
continuous outcome variables on geostatistical inference. Model-based geostatis-
tics (MBG) [1] is a likelihood-based paradigm that allows us to carry out spatially
continuous predictive inference on an outcome of interest using a spatially discrete
set of data. Over the last two decades, MBG has been increasingly used to map
the prevalence of infectious diseases [46], especially in low-resource settings where
disease registries are non-existent or geographically incomplete. In this context,
there have been global efforts to increase the use of rapid diagnostic tests for dis-
eases such as malaria and HIV [47–50], which are typically recorded as binary
by labelling the tested individuals as either positive or negative. In other cases,
instead, dichotomization is first carried out on a continuous disease indicator vari-
able and a geostatistical model is then developed on the binary outcome. For
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example, in Zimmerman et al. [51], a continuous score quantifying the deviation
from normal growth in children is dichotomized in order map stunting prevalence;
following a similar approach, Magalhaes et al. [52] fit a binomial geostatistical
model to dichotomized continuous haemoglobin densities so as to map anaemia
prevalence in West Africa.
The effects of dichotomization on geostatistical inference have not been fully un-
derstood and, to the best of our knowledge, this is the first study that attempts
to pursue this objective in the context of prevalence mapping. More specifically,
in this paper, we provide answers to the following questions: 1) How does spatial
correlation affect the loss of information and the estimation of regression relation-
ships? 2) Can dichotomization lead to substantially different and more uncertain
spatial predictions in disease prevalence? 3) How can we use linear geostatistical
models to map disease prevalence and thus avoid the drawbacks of dichotomiza-
tion?
The structure of the paper is as follows. In section 2.2 we describe the geostatistical
modelling framework for disease prevalence mapping, and outline the differences
and links between geostatistical models based on binary and continuous outcomes.
In section 2.3, we first explore the information loss due to dichotomization in terms
of the Fisher’s information for two observations. We then develop a metric which
can be used to assess the loss of information for the estimation of the regression
coefficients of any geostatistical model. We also carry out a simulation study
to extend our investigation to the estimation of the covariance parameters and
spatial predictions for prevalence. In section 2.4 we illustrate two applications
on the mapping of anaemia and stunting prevalence in Africa. Section 2.5 is a
concluding discussion.
In what follows, fitting of geostatistical models and geostatistical prediction have
been carried out using the Monte Carlo maximum likelihood method implemented
in the PrevMap package [53] available from the Comprehensive R Network archive
(cran.r-project.org. In this paper, maximum likelihood estimation is facilitated
by unconstrained and box-constrained optimization using PORT routines through
the nlminb function in R.
2.2 The link between geostatistical models for
continuous and binary outcomes
Consider data from a cross-sectional survey where information on a continuous
health outcome, the random variable Yij, is collected through examination of ni
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individuals residing at location xi for j = 1, . . . , ni and i = 1, . . . ,m. We then
assume that conditionally on a spatial Gaussian process S = {S(x) : x ∈ R2},
the Yij are random Gaussian variables with mean µij + S(xi) and variance τ 2.
From the linear properties of Gaussian distributions, we can write the model in
the following compact form
Yij = µij + S(xi) + Zij, (2.1)
where Zij are i.i.d. Gaussian variables with mean zero and variance τ 2, representing
unexplained individual-level variation and the mean component µij is modelled as
a linear regression taking the form
µij = α + β>d(xi) + γ>eij
where we distinguish between covariates, d(xi), that express properties of the lo-
cations and covariates, eij, for individual traits e.g. age and gender.
We model S(x) as a stationary and isotropic Gaussian process with mean zero,
variance σ2 and correlation function Cor {S(x), S(x′)} = ρ (u) where u = ||x−x′||
denotes the Euclidean distance between x and x′. In the remainder of this paper,
we shall define ρ (·) to be an exponentially decaying function with scale parameter
φ, i.e. ρ(u) = exp{−u/φ}.
Based on a predefined threshold c, whose exceedance or not defines the disease
status of an individual, we define the binary outcome Ỹij as
Ỹij =
1 if Yij < c0 if Yij ≥ c , (2.2)
with Ỹij = 1 indicating a positive case for the disease under investigation and
Ỹij = 0 for a negative case. Note that in some diseases, the threshold is dependent
on individual characteristics like age or sex, as demonstrated in the ‘Applications’
section of this paper.
From the model of the continuous outcome in (2.1), it follows that the model for
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where Φ(·) is the cumulative density function of a standard Gaussian variable.
Hence, the resulting model for Ỹij is a Binomial geostatistical model with probit
link function and linear predictor
ηij = Φ−1(pij) = µ̃ij + S̃(xi) (2.4)
where µ̃ij = −µij/τ and S̃(xi) = −S(xi)/τ .
The functional relationships that link the parameters of the geostatistical model
for Ỹij with those of the model for Yij are the following
α̃ = (c− α)/τ
β̃ = −β/τ
γ̃ = −γ/τ
σ̃2 = σ2/τ 2
. (2.5)
The above equations can thus be used to obtain the parameter estimates for a
geostatistical model for Ỹij by transforming the parameter estimates from the geo-
statistical model for Yij. Note that it is not possible, instead, to map the estimates
from the model for Ỹij into those for Yij because the parameter τ 2 cannot be es-
timated from binary data. The unstructured component Zij is in fact integrated
out in (2.4) and, as shown in (2.5), all the parameters on the left hand-side are
expressed as a ratio between τ and all other parameters in the model for Yij. Fi-
nally, φ is not included in (2.5), since the scale of the spatial correlation of S̃(x)
is the same as that of S(x).
2.3 Quantifying the effects of dichotomization
In Section 2.3.1, we first study the loss of information due to dichotomization for
the estimation of the mean of the process using an intercept-only model, when all
other parameters are known. In Section 2.3.2, we carry out a simulation study to
the more common case when all parameters are unknown. Here we study the effect
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on dichotomization on parameter estimation. In both sections, we shall restrict
our attention to the scenario of a single observation per location, hence we set
ni = 1 for all i and drop the j subscript.
2.3.1 Unknown regression coefficients and known covariance parame-
ters
2.3.1.1 Special case of m=2 for an intercept-only model
The objective in this section is to quantify the loss of information in terms of
the expected Fisher information (EFI) with respect to α̃, the parameter which
regulates the mean level of disease prevalence. Here, we restrict our attention to the
simpler case of two observations at two locations, hence m = 2 and n1 = n2 = 1,
for an intercept-only model. As it will be shown in the applications of Section
2.4, this simpler scenario provides useful insights on the effects of dichotomization
which are consistently observed in the case of more than two observations. A more
general scenario, however, shall also be considered in the next section.
We re-express the linear geostatistical model for a continuous outcome Yi as
Yi = α + S(xi) + Zi, for i = 1, . . . ,m (2.6)
where S(xi) is a stationary and isotropic Gaussian process with the same properties
as defined in equation (2.1).
Let ΣY = Σ + τ 2I be the covariance matrix of the vector Y = (Y1, . . . , Ym), with
Σ and I denoting the spatial covariance matrix with (i, j)-th entry σ2 exp{−‖xi−
xj‖/φ} and an m by m identity matrix, respectively.
In order to quantify the loss of information that arises from the dichotomization
of the Yi, we first re-parametrize the linear model in (2.6) with respect to the
prevalence parameters as defined in (2.5); note that α = c − τ α̃. We then obtain
the EFI for α̃ under the linear model, given by
IY (α̃) = τ 21TΣ−1Y 1, (2.7)
where 1 is a vector with all entries equal to 1.
In the case of the dichotomized outcome Ỹi, the computation of the EFI is further
complicated by the fact that the log-likelihood function is not available in closed
form. More specifically, this is given by the marginal distribution of the outcome
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where f(s̃) is the density of a multivariate Gaussian distribution with mean zero
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= exp{g(ỹ|s̃; α̃)} (2.9)
where Φ−1(pi) = α̃ + S̃(xi). To obtain the EFI for α̃, we first take the second






























Finally, we average over the distribution of Ỹ







Since the above quantity is not available in closed form we compute IỸ (α̃) using
Monte Carlo methods.
To quantify the loss of information, we then use the following metric R(α̃) =









where Φ′(·) and Φ′′(·) are the first and second derivative of Φ(·), respectively.
Fedorov et al. [3] have shown that IỸ (α̃) ≤ IY (α), and that the lower limit of
(2.11) is about 36%. Also, note that (2.11) is not dependent on m.
To compute the integrals which define −d2 logL(α̃)/d2α̃, we use a quadrature ap-
proach based on Quasi Monte Carlo methods. Finally, for the computation of the
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expectation in IỸ (α̃), we use 10,000 samples and vary the spatial correlation be-
tween the two observations over ρ ∈ {i/10; i = 1, . . . , 7}. Figure 2.1 shows different
curves of R(α̃), as a percentage, by setting σ2 = 1 and letting τ 2 vary over the
set {0.5, 1, 2}. Notice that these curves are symmetric with respect to 0, although
they are shown only for positive values of α̃. Across all three panels of Figure 2.1,
we observe that increasing values of ρ lead to a reduction in the loss of informa-
tion, although such reduction becomes smaller when the data are more noisy, i.e.
when τ 2 also increases. Most notably, the largest loss of information is observed
for values of prevalence close to 100% and 0% corresponding to large positive and
negative values for α̃, respectively. The variance τ 2 of the unstructured residuals
Zi also plays a very important role as shown by the dramatic increase in R(α̃) for
τ 2 = 2, with all curves placed above R(α̃) = 0.65.









































































Figure 2.1: Curves for R(α̃), shown as a percentage, by fixing σ2 = 1 and varying
τ2 ∈ {0.5, 1, 2} and the spatial correlation between two observations
ρ ∈ {i/10; i = 1, . . . , 7}.
2.3.1.2 General case m > 2
For the general case of more than two locations (i.e. m > 2), the effects of
dichotomization will also be dependent on the spatial arrangement of the sampled
locations. In this section, we develop a metric that allows to quantify the potential
loss of information due to dichotomization of continuous outcomes with respect the
estimation of the regression coefficients θ = (α̃, β̃, γ̃) of any geostatistical model as
defined by (2.1).
In order to lower the computational burden, we first approximate the likelihood
function of both the continuous and dichotomized data using a composite likeli-
hood approach [54]. More specifically, we consider all possible pairs of Ỹij and
treat each of these as independent bivariate distributions. Let Ỹh and Ỹk denote
page 20
Chapter 2. Dichotomization in geostatistical inference
the vectors of binary outcomes associated with locations xh and xk and which are
obtained through dichotomization of Yh and Yk, respectively. We then write










In the above equation the bivariate probability functions f(ỹh, ỹk; θ̃) are expressed
by the following integral in two dimensions












consists of a product of nh + nk probability functions for the
binary observations in yh and yk.
Let θ̂LM denote the maximum likelihood estimates of θ obtained from the linear
model using the system of equations in (2.5). In order to understand how more or
less dispersed the composite likelihood becomes after dichotomization, we proceed
as follows. We first compute the second derivative of the composite log-likelihood








For a continuous outcome Y , we have








where Σhk is covariance matrix between Yh and Yk, and Dh and Dk are the design
matrices associated with locations xh and xk, respectively. To quantify the change
in the dispersion of the composite likelihood around θ̂LM , we finally compute
CLD(θ̂LM) = log{det[−H−1Ỹ (θ̂LM)]} − log{det[−H
−1
Y (θ̂LM)]}
= log{det[−HY (θ̂LM)]} − log{det[−HỸ (θ̂LM)]}
where det(A) denotes the determinant of a square matrix A. Large values of
CLD(θ̂LM) indicate a more dispersed composite likelihood around θ̂LM for the
binary data Ỹ , which we interpret as evidence of loss of information due to di-
chotomization. Also, note that computation of CLD can be carried out without
fitting any Binomial geostatistical model.
In the applications of Sections 2.4.1 and 2.4.2, we compute the CLD metric, by
plugging-in the maximum likelihood estimates for the covariance parameters from
the linear geostatistical models.
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2.3.2 Simulation study
The objective of this simulation is to quantify the effects of dichotomization on
parameter estimation and spatial predictions of prevalence. To this end we con-
sider the linear model for Yi as specified in (2.6) and its dichotomization using a
threshold c to give Ỹi = 1 if Yi < c and 0 otherwise.
In the simulation, we set α = 0 and σ2 = 1. We consider several scenarios obtained
through all possible combinations of values for the model parameters defined in
Table 2.1. For a given scenario, we simulate 1,000 data-sets of both continuous
and dichotomized outcomes and fit their corresponding geostatistical models. We
use a regular grid covering the unit square with spacing of 1/14 (i.e. a regular grid
of 15 x 15 equally spaced points), to give a sample size of m = 225. For each of





at each of the grid points. We summarize the results using the
bias and mean square error (MSE) and, for the prevalence predictions, average
these two indices over the grid locations.
Tables 2.2 and 2.3 report the results for the model parameters and spatial predic-
tions for prevalence, respectively. Overall, bias and MSE for α̃ and φ are consis-
tently smaller in the model fitted to the continuous data (C) than for that fitted to
the binary data (B). In the case of σ̃2, instead, the performance of both models is
strongly affected by the scale of the spatial correlation φ: for φ = 0.1 the model B
outperforms model C in terms of bias and MSE, whilst the opposite is observed for
φ = 0.2. A possible explanation for this may be due to the fact that in the linear
geostatistical model, higher spatial correlation helps to better separate the indi-
vidual contributions of the signal component S(xi) and the noise component Zi to
the total variation in the outcome Yi, thus improving the estimation of σ̃2 = σ2/τ 2.
In the case of the binary data, instead, S̃(xi) is the only source of over-dispersion
and, as a result of this, a higher spatial correlation leads to a larger number of
concordant binary outcomes and, therefore, to a poorer estimate of the variance
of S̃(xi). Also, we notice that the estimation of σ̃2 and φ does not appear to be
affected by the threshold c, unlike α̃. Finally, the results for the spatial predictions
of prevalence show that the performance of model C is unaffected by changes in c
and τ 2, while for φ = 0.2 the predictions have slightly lower MSE than for φ = 0.1.
Model B, instead, delivers predictions with higher bias for increasing c which can
be partly explained by the positive increase in the bias in the estimates of α̃ for
increasing c.
We have also conducted further simulations under the same scenarios defined in
Table 2.1 but for a larger sample size m = 450, by placing additional points on a
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regular grid adjacent to the unit square so as to cover the rectangle [0, 2]× [0, 1].
The results, reported in the supplementary material (Tables S1 and S2), lead to
the same conclusions drawn for m = 225.
Table 2.1: True values for τ2, φ and c used in the simulation study.
Symbol Variations
Variance of the nugget effect τ 2 0.5, 1, 2
True scale of spatial correlation φ 0.1, 0.2
Cut-off c 0, 0.2, 0.4
Table 2.2: Bias and mean square error (in brackets) for α̃, σ̃2 and the estimate φ̂
obtained from the geostatistical models fitted the binary (B) and continuous (C)
outcomes.
c=0 c=0.2 c=0.4
Parameter τ 2 φ B C B C B C
α̃ 0.5 0.1 0.009 (0.168) 0.005 (0.113) 0.063 (0.312) 0.017 (0.115) 0.157 (0.263) 0.042 (0.139)
1 0.1 -0.009 (0.126) -0.008 (0.068) 0.060 (0.409) 0.004 (0.064) 0.153 (0.119) 0.041 (0.080)
2 0.1 -0.006 (0.079) -0.003 (0.036) 0.077 (0.493) 0.022 (0.040) 0.148 (0.169) 0.050 (0.054)
0.5 0.2 -0.025 (0.624) -0.013 (0.296) 0.156 (0.648) 0.048 (0.282) 0.238 (0.722) 0.028 (0.303)
1 0.2 -0.018 (0.332) -0.007 (0.150) 0.093 (0.585) 0.008 (0.137) 0.215 (0.323) 0.025 (0.145)
2 0.2 -0.007 (0.185) -0.004 (0.080) 0.106 (0.566) 0.023 (0.080) 0.164 (0.272) 0.022 (0.088)
σ̃2 0.5 0.1 -0.011 (1.296) 0.788 (5.843) -0.033 (1.324) 0.604 (5.170) 0.022 (1.594) 0.734 (5.741)
1 0.1 0.234 (0.787) 0.822 (5.953) 0.190 (0.688) 0.750 (5.255) 0.224 (0.701) 0.741 (5.942)
2 0.1 0.211 (0.326) 0.672 (5.047) 0.217 (0.364) 0.600 (4.961) 0.204 (0.324) 0.653 (4.833)
0.5 0.2 1.641 (8.894) 0.527 (3.091) 1.784 (12.672) 0.574 (3.268) 1.566 (8.464) 0.515 (3.401)
1 0.2 1.162 (3.755) 0.399 (1.712) 1.064 (3.243) 0.372 (1.619) 1.048 (2.949) 0.365 (1.671)
2 0.2 0.548 (0.871) 0.254 (1.104) 0.575 (1.074) 0.304 (1.829) 0.534 (0.910) 0.341 (1.707)
φ̂ 0.5 0.1 0.088 (0.016) 0.007 (0.002) 0.084 (0.015) 0.009 (0.002) 0.085 (0.015) 0.007 (0.002)
1 0.1 0.071 (0.014) 0.004 (0.003) 0.072 (0.014) 0.006 (0.004) 0.074 (0.015) 0.006 (0.003)
2 0.1 0.060 (0.017) 0.010 (0.007) 0.063 (0.022) 0.009 (0.007) 0.056 (0.014) 0.010 (0.006)
0.5 0.2 0.076 (0.029) -0.017 (0.011) 0.083 (0.034) -0.020 (0.008) 0.076 (0.030) -0.021 (0.009)
1 0.2 0.068 (0.030) -0.014 (0.016) 0.058 (0.027) -0.028 (0.010) 0.061 (0.034) -0.023 (0.013)
2 0.2 0.032 (0.025) -0.024 (0.019) 0.037 (0.031) -0.024 (0.016) 0.028 (0.019) -0.032 (0.015)
Table 2.3: Bias and mean square error (in brackets), averaged over a 1/14 by 14
regular grid covering the unit square (hence, m = 225), for the spatial predictions of
prevalence obtained from the geostatistical models fitted to the binary (B) and
continuous (C) outcomes.
c=0 c=0.2 c=0.4
τ 2 φ B C B C B C
0.5 0.1 0.001 (0.060) 0.001 (0.039) 0.018 (0.059) 0.001 (0.038) 0.034 (0.058) 0.001 (0.036)
1 0.1 -0.001 (0.051) 0.001 (0.038) 0.018 (0.051) 0.001 (0.038) 0.038 (0.050) 0.001 (0.036)
2 0.1 -0.001 (0.040) 0.001 (0.033) 0.020 (0.040) -0.001 (0.033) 0.038 (0.040) -0.002 (0.032)
0.5 0.2 -0.001 (0.042) 0.001 (0.030) 0.013 (0.042) -0.001 (0.030) 0.025 (0.041) -0.001 (0.029)
1 0.2 0.001 (0.037) 0.001 (0.028) 0.014 (0.037) -0.001 (0.028) 0.030 (0.036) -0.001 (0.027)
2 0.2 -0.001 (0.031) 0.001 (0.024) 0.019 (0.031) -0.001 (0.024) 0.034 (0.031) -0.002 (0.024)
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2.4 Applications
2.4.1 Mapping anaemia prevalence in Ethiopia
In this section, we analyse data collected from the Beyond Garki project 1. This
project consisted of cross-sectional surveys which were conducted in selected study
sites in Ethiopia and Uganda to monitor changes in malaria risk in the context of
interventions that had been implemented. The study sites were defined as a ‘health
centre and the catchment population in selected villages around it’. Here we subset
the data for the Hembecho site, in Ethiopia, collected during the 2012 survey,
where a random sample of households were selected from a list of enumerated
households from all villages within a radius of 2 to 6 kilometers of the health
facility. Among the data obtained in this survey were continuous measurements
of haemoglobin density (g/dL), taken from blood samples of individuals living in
the households. These measurements were then used to determine the anaemia
status of individuals. Further details of the study design and data collection can
be found in Abeku et al. [55].
In this analysis, the objective is to identify areas where the anaemia prevalence
is highly likely to exceed a 20% threshold for 20 year old women. Hence, we
map and compare exceedance probabilities from the geostatistical models for the
continuous and binary outcomes. The chosen threshold for anaemia prevalence
has clinical, operational and public health significance for policy decisions, with
the World Health Organisation (WHO) classifying 20% anaemia prevalence as
‘moderate public health significance’[44]. Finally, the rationale for carrying out
predictions for 20 year old women is that one of the key WHO Global Nutrition
Targets for 2025 is a 50% reduction of anaemia in women of reproductive age [44,
56], which is defined as 15-49 years [57].
The data-set contains information on 1712 individuals distributed over 457 house-
holds, with an average of 3.7 individual in each household. The continuous outcome
variable, Yij, is the log-transformed haemoglobin density for the j-th individual
at the i-th household. To account for the non-linear relationship between the
log-transformed anaemia density and age, as shown in Figure 2.2, we use a linear
spline with knots at 15 and 30 years. Our proposed linear model for Yij is thus
expressed as
Yij = α +
3∑
h=1
βhbh(aij) + β4dij + S(xi) + Zij, (2.13)
1www.malariaconsortium.org/beyondgarki
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where: aij is the age, in years, of an individual; dij is a binary indicator of the sex
of an individual, with “female” as reference category; bh(·) are the base functions
of the linear spline defined as b1(a) = a, b2(a) = max{0, a − 15} and b3(a) =
max{0, a− 30}.
Figure 2.2: (a) locations of the households in the survey; (b) scatter plot of the
log-transformed haemoglobin density against age, in years. The dashed red line in the
in panel (b) is a least square fit of the linear spline defined in the main text of Section
2.4.1.
Dichotomization of Yij results in the binary outcome variable Y ∗ij indicating anaemia
status, where Y ∗ij = 1 denoting a positive case and Y ∗ij = 0 a negative case for severe
anaemia. In order to classify an individual as positives or negatives, thresholds for
severe anaemia have been applied using individual-level information on age, sex




cij − µij − S(xi)
τ
)
where cij is the logarithm of the threshold values which must now be incorporated
as an additional covariate into the linear predictor, i.e.
Φ−1(pij) = α̃ +
3∑
h=1
β̃hbh(aij) + β̃4dij + β̃5cij + S̃(xi)
where β̃5 = 1/τ .
Table 2.5 reports the maximum likelihood estimates and 95% confidence intervals
of the model parameters for the binary and continuous outcomes. The linear
geostatistical model gives an estimate for τ 2, the variance of Zij, of about 1.133×
10−2 (95% CI: 1.050× 10−2, 1.222× 10−2) and for σ2 of about 1.558× 10−3 (95%
CI: 0.954×10−3, 2.422×10−3), yielding an estimated noise to signal ratio τ 2/σ2 of
about 7.3. The CLD metric (Section 2.3.1.2 ) is 771.235 which indicates a larger
dispersion of the composite likelihood for the binary data than for the continuous
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Table 2.4: Thresholds of haemoglobin densities (g/dL) for anaemia diagnosis [44].
Anaemia
Age or Sex group Mild Moderate Severe
Children (Age 6-59 months) 10.0-10.9 7.0-9.9 < 7.0
Children (Age 5-11 yrs) 11.0-11.4 8.0-10.9 < 8.0
Children (Age 12-15yrs) 11.0-11.9 8.0-10.9 < 8.0
Pregnant women (Age > 15yrs) 10.0-10.9 7.0-9.9 < 7.0
Non-pregnant women (Age > 15 yrs) 11.0-11.9 8.0-10.9 < 8.0
Men (Age > 15 yrs) 11.0-12.9 8.0-10.9 < 8.0
data. We observe that the estimates of the parameters are all comparable except
for σ̃2 (= σ2/τ 2), as indicated by the non-overlapping confidence intervals from
the two models. More importantly, we observe that the confidence intervals for
the regressions coefficients are narrower for the linear model.
Figure 2.3 shows the resulting anaemia prevalence predictions for 20 year old
women from the two models. While the overall pattern of predicted prevalence is
similar between the models (see Figures 2.3(a) and 2.3(b)), there are non-negligible
differences ranging from -8.23% to 7.85% prevalence (Figure 2.3(c)). Similarly,
the maps of the exceedance probability qualitatively show similar spatial patterns
(figures 2.3(d) and 2.3(e)). However, we identify small areas where the differences
range from -38.6% to 31.20% (Figure 2.3(f)).
Table 2.5: Maximum likelihood estimates with associated 95% confidence intervals
(CI) for the geostatistical models fitted to the anaemia data.
Binomial model Linear model
Term Estimate 95% CI Estimate 95% CI
β̃1 0.079 (-0.220, 0.378) -0.278 (-0.377, -0.179)
β̃2 -0.066 (-0.124, -0.008) -0.115 (-0.131, -0.100)
β̃3 0.052 (-0.025, 0.129) 0.097 (0.072, 0.122)
β̃4 0.071 (0.021, 0.121) 0.050 (0.031, 0.069)
σ̃2 0.527 (0.395,0.705) 0.138 (0.082, 0.218)
φ 0.325 (0.201,0.396) 0.250 (0.093, 0.549)
2.4.2 Mapping stunting prevalence in Ghana
The data analysed in this section are from the 2014 Demographic and Health
Survey2 (DHS) conducted in Ghana. DHS are nationally representative household
surveys conducted about every 5 years, and provide data on health and population
indicators for monitoring and impact evaluation across Africa. The DHS surveys
follow a stratified two-stage cluster design where in the first stage, enumeration
areas are selected from previous population census files, followed by a second stage
2dhsprogram.com
page 26
Chapter 2. Dichotomization in geostatistical inference
Figure 2.3: Predicted anaemia prevalence for a 20 year old woman. Upper panels:
prevalence surfaces from the binomial model (a) and the linear models (b), and the
difference between the first and the second (c). Lower panels: exceedance probabilities
for a 20% prevalence threshold obtained from the binomial (d) and the linear models
(e), and their difference (f). This study area is within 2–6 kms radius of a local health
facility
where, for each selected enumeration area, samples of households are sampled from
updated lists of households to generate the so called sampling clusters. The GPS
locations of a sampling cluster is then assigned to each of the individuals falling
within that cluster.
Among the health indicators collected in this survey are anthropometric measure-
ments, which are used to calculate the height-for-age Z-score (HAZ). HAZ are
standardized scores which indicate the standard deviation from the mean of chil-
dren’s heights based on the WHO growth standards [58, 59] and are comparable
across ages and sex. HAZ values below −2 are taken as an indication of stunted
growth.
One of the key WHO Global Nutrition Targets for 2025 is a 40% reduction in
the number of children under-5 who are stunted [56, 60]. Additionally, a stunting
prevalence above 40% is considered a high public health significance [61]. Accord-
ingly, we aim to map the exceedance probability of 40% stunting prevalence for
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a 2 year old who falls in the lowest wealth index category and whose mother has
poor education.
The data include information on children under 5 years old, with a total of 2671
sampled children and 410 clusters, giving an average of 6.5 children per cluster.
The continuous outcome variable, Yij, is the HAZ for child j in cluster i. Figure
2.4 (a) shows the empirical relationship between HAZ and age in years. Using a
similar approach of the previous analysis, we capture the non-linear relationship
with a linear spline having knots at 1 and 2 years. Hence, the resulting linear
geostatistical model is
Yij = α +
3∑
h=1
βhbh(aij) + β4dij + β5eij + S(xi) + Zij, (2.14)
where: aij is the age of a child; the basis functions of the linear splines are b1(a) = a,
b2(a) = max{0, a − 1} and b2(a) = max{0, a − 2}; dij is a score of maternal edu-
cation, taking integer values from 1=”Poorly educated” to 3=”Highly educated”;
eij is a wealth index of the household, taking integer values from 1=”Poor” to
3=”Rich”.
Figure 2.4: Figure (a) shows the spatial distribution of households included in the
analysis, while (b) shows the relationship between HAZ and age. The red dashed line
in panel (b) corresponds to a least square fit of the linear spline defined in (2.14).
The maximum likelihood estimates and associated 95% confidence intervals are
shown in Table 2.6. We also report that the estimates for σ2 and τ 2 from the linear
geostatistical model are 0.071 (95% CI: 0.037, 0.126) and 1.396 (95% CI: 1.318,
1.477), respectively. Hence, the estimated ratio τ 2/σ2 is about 20, indicating that
the data are substantially more noisy than those analysed in the previous section.
This is also reflected in the CLD metric yielding a value of 9667.012 which is
substantially larger than that reported for the anaemia analysis. Following from
the results of Section 2.3, this suggests that the effects of dichotomization on
page 28
Chapter 2. Dichotomization in geostatistical inference
Table 2.6: Maximum likelihood estimates with associated 95% confidence intervals
(CI) for the geostatistical models fitted to the data on childhood malnutrition.
Binomial model Linear model
Term Estimate 95% CI Estimate 95% CI
β̃1 0.772 (-0.002, 1.545) 0.554 (0.338, 0.771)
β̃2 0.774 (-0.331, 1.879) 0.168 (-0.168, 0.502)
β̃3 -1.942 (-2.463, -1.421) -0.830 (-1.024, -0.639)
β̃4 -0.721 (-1.174, -0.269) -0.139 (-0.239, -0.039)
β̃5 -0.444 (-0.666, -0.221) -0.259 (-0.332, -0.186)
σ̃2 0.256 (0.102, 0.528) 0.051 (0.026, 0.091)
φ 157.301 (59.706, 341.451) 51.899 (14.657, 136.232)
geostatistical inference will also be stronger. Note that this may also be affected
by the the spatial scale of Ghana, which is much larger than for the Ethiopia
site. We observe that the estimates of the regression coefficients are concordant in
sign but the size of the effects of the covariates are different as indicated by the
non-overlapping confidence intervals; as in the previous section, we observe that
the confidence intervals for the regression coefficients from the linear model are all
narrower. The estimated σ̃2 and φ are also substantially different, with the linear
geostatistical model providing lower estimates and narrower confidence intervals
for both parameters.
The differences in the parameter estimates are also reflected in Figure 2.5 which
shows the predicted surfaces of stunting prevalence and the exceedance probabil-
ities from the two models. These predictions are for a 2 year old who falls in
the lowest wealth index category, and whose mother has poor education. Quali-
tatively, both models identify high and low levels of prevalence in the same areas.
However, the differences in the predicted prevalence between the binomial model
(Figure 2.5(a)) and the continuous model (Figure 2.5(b)), range from -9.38% to
19.98% prevalence (Figure 2.5(c)). Most notably, the binomial model presents
much smoother maps than those from the linear model. For example, the bino-
mial model identifies a single large hot-pot in the eastern part of Ghana, as being
highly likely to exceed 40%. The linear model, instead, shows three neighbouring
hot-spots in the same area. The differences in exceedance probabilities between
the two models range from -51.50% to 64.90% (Figure 2.5(f))
2.5 Discussion
Understanding of the effects of dichotomization of continuous outcomes is espe-
cially important in medical research where cut-offs are used for diagnosis. These
can be derived using different approaches: empirical approaches, where thresh-
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Figure 2.5: Predicted stunting prevalence for a 2 year old who falls in the lowest
wealth index category and whose mother has poor education. Upper panels: prevalence
surfaces from the binomial model (a) and the linear models (b), and the difference
between the first and the second (c). Lower panels: exceedance probabilities for a 40%
prevalence threshold obtained from the binomial (d) and the linear models (e), and
their difference (f).
olds are obtained through summary statistics of measurements taken from healthy
individuals; clinical approaches, which utilize a specified threshold above which
symptoms and complications become more frequent; prognostic approaches, where
a threshold is defined based on clinical results which may be symptom-less but
carry an adverse prognosis; or, finally, operational approaches, where a threshold
may be based on management and/or operational guidelines [43]. In this study,
we have investigated the effects of dichotomization in the context of geostatistical
modelling of disease prevalence data through a simulation study and two appli-
cations, and have proposed a likelihood-based metric to quantify the potential
loss information arising from this practice. All of these provided evidence that
dichotomization of the data can lead to substantial loss of information for both
parameter estimation and spatial prediction. We found that spatial correlation
may alleviate the effects of dichotomization for parameter estimation but the in-
crease in uncertainty and bias still remained substantially larger than those of the
linear model. In particular, one of the key factors that more strongly affects the
loss of accuracy and precision is the distance of the threshold from the mean of
the underlying process. As such distance increases, both the bias and the MSE in
page 30
Chapter 2. Dichotomization in geostatistical inference
the estimation of the mean component and in the spatial predictions of prevalence
also increase. Another important factor is the magnitude of the noise variance τ 2
relative to the signal variance σ2. This was especially evident in the application of
Section 2.4.1, where a τ 2 about 20 times larger than σ2 led to the loss of the fine
scale features in the spatial pattern of disease prevalence.
As shown in the application of Section 2.4.1, when thresholds vary across indi-
viduals, these should be accounted for in the model for binary data, an aspect
that has been ignored in previous studies of anaemia mapping. Also, this could
be especially problematic if some of the covariates on which the the cut-offs are
based are missing (e.g. the pregnancy status of a woman). An additional problem
that arises in the context of anaemia epidemiology, is that the cut-offs described
in Table 2.4 are based on guidelines from 1992 and 2001 [44] which may be subject
to amendment as scientific research or clinical practices evolve.
We have only considered the case of a Gaussian distribution for the unstructured
component Zi. Assuming a symmetric distribution for Zi implies that, on average,
misclassifications of individuals as false positives and false negatives balance out
after dichotomization. However, if Zi followed a skewed distribution, this could
introduce additional bias in the geostatistical model for binary data as more in-
dividuals could be misclassified as either false positives or false negatives. Hence,
we expect that under these scenarios the negative effects of dichotomization on
geostatistical inference would be even stronger than those shown in this study.
It is important to note that in our study we compared the performance of binary
and linear geostatistical models for cut-offs that are dependent on the scale of the
continuous measurement. In other cases, the Yi may follow a mixture distribution
with a probability mass in zero. For example, malaria parasite density may exhibit
this feature if a large proportion of the general population has not been infected
and is thus clear of parasites. In this case dichotomization of the continuous
outcome as Y ∗i = 1 if Yi > 0 and Y ∗i = 0 otherwise Yi = 0, would not lead to any
loss of information. Similarly, where the distinction between positive and negative
is minimal, for example where there is a negligible overlap between two latent
populations in a mixture distribution (e.g, seronegative and seropositive in the
case of malaria serology analysis), then loss of information may not be a problem.
A final remark relates to the computational burden of binary and linear geosta-
tistical models. The likelihood function of the latter can be, most of the times,
expressed in closed form, while the former requires numerical procedures based on
analytical or Monte Carlo approximations of the likelihood function in order to
be fitted. Hence, the increase in the computational burden is a further reason to
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avoid dichotomization of the data.
2.6 Conclusion
In the context of geostatistical inference, dichotomization of continuous outcomes
can lead to a substantial loss of efficiency for both parameter estimation and spatial
prediction. Such loss is further compounded as cut-offs used for dichotomization
are further away from the mean. In addition, dichotomization can also result in the
loss of fine scale features of disease prevalence, especially in the presence of a large
noise to signal ratio. The findings in this study strongly support the conclusions
drawn from previous studies that, whenever feasible, dichotomization should be
avoided by developing models for the continuous measurements which can then be
used to estimate prevalence.
CRediT authorship contribution statement
Irene Kyomuhangi: Conceptualization, Methodology, Formal analysis, Investi-
gation, Data curation, Visualization, Writing-original draft.
Tarekegn A. Abeku, Matthew J. Kirby and Gezahegn Tesfaye: Resources,
Writing-review and editing
Emanuele Giorgi: Conceptualization, Methodology, Formal analysis, Supervi-
sion, Writing-review and editing.
Acknowledgements
We thank Dr. Luigi Sedda (Lancaster University) for his comments on the manuscript,
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Chapter 3. A unified modelling framework for malaria serology analysis
Summary
Serology data are an increasingly important tool in malaria surveillance,
especially in low transmission settings where the estimation of parasite-
based indicators is often problematic. Existing methods rely on the use of
thresholds to identify seropositive individuals and estimate transmission in-
tensity, while making assumptions about the temporal dynamics of malaria
transmission that are rarely questioned. Here, we present a novel threshold-
free approach for the analysis of malaria serology data which avoids di-
chotomization of continuous antibody measurements and allows us to model
changes in the antibody distribution across age in a more flexible way. The
proposed unified mechanistic model combines the properties of reversible
catalytic and antibody acquisition models, and allows for temporally vary-
ing boosting and seroconversion rates. Additionally, as an alternative to the
unified mechanistic model, we also propose an empirical approach to anal-
ysis where modelling of the age-dependency is informed by the data rather
than biological assumptions. Using serology data from Western Kenya,
we demonstrate both the usefulness and limitations of the novel modelling
framework.
Keywords: malaria serology; reversible catalytic model; antibody acquisi-
tion model; mixture model; malaria antibody; seroprevalence.
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3.1 Introduction
Despite the significant progress made in the control of malaria worldwide, this
still remains a significant public health threat in many countries, particularly in
Sub-Saharan Africa [11]. Even with the decline of malaria prevalence in endemic
countries [62], there are still challenges which require robust mechanisms for mon-
itoring malaria transmission and evaluation of elimination efforts [11].
Classical methods of estimating malaria risk rely on the detection of the Plasmod-
ium parasite in humans and mosquito populations. Plasmodium falciparum (Pf)
is the most prevalent malaria parasite in African, while Plasmodium vivax (Pv)
dominates in the Americas and South East Asia [11]. Parasite prevalence (PrP) is
determined by the proportion of infected individuals at time of data collection [20,
21], while the entomological inoculation rate (EIR) is the rate at which individuals
are bitten by infectious mosquitoes [22]. Both of these measures may very over
time due to the joint effect of several environmental factors, and the precision with
which they can be estimated is often low, particularly in low transmission settings
[20, 21]. Additionally, the collection of entomological data is labour-intensive, ex-
pensive, and excludes the recruitment of children, due to ethical considerations
[23–25].
Several studies have shown the utility of serological markers as a viable alternative
for estimating transmission intensity. Because of the persistence of antibodies,
serological markers 1) provide information on cumulative exposure to the pathogen
over time, 2) smooth out the effect of seasonality in transmission, and 3) allow
estimation of transmission intensity with more feasible sample sizes even in low
transmission settings [21, 25, 26, 28].
Antibody responses to blood-stage malaria parasites provide protection against
clinical disease, however this response does not confer sterile immunity, therefore
individuals remain susceptible to repeated infections [16, 17]. In malaria endemic
settings, antibody levels generally increase as individuals become older, are boosted
by repeated infection, and decay in the absence of re-infection [18, 20]. Using
existing knowledge on the dynamics of transmission, malaria serology models aim
to derive a measure of transmission which can be used to monitor trends in endemic
areas over time.
The most commonly used approach to estimate malaria transmission intensity is
based on the classification of individuals as seronegative and seropositive which
is then used as the input of a reversible catalytic model (RCM), to estimate
the seroconversion rate, which quantifies the rate at which individuals convert
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from seronegative to seropositive. [20, 25, 26]. Assuming latent seronegative and
seropositive distributions in the sample, mixture models fitted to the antibody
distribution are used in order to identify optimal thresholds for the classification
of individuals into seropostives and seronegatives [20, 63].The major drawback of
this approach is that it can generate biased estimates of transmission intensity as
a result of the misclassification, especially among inconclusive cases whose prob-
abilities of belonging to either group are close to 50% [64, 65]. Bollaerts et al.
[64] and Hens et al. [65] propose a ‘direct’ method of estimating seroprevalence
from continuous antibody measurement using an underlying mixture model, which
avoids the use of thresholds and thus the bias arising from the misclassification of
individuals. In those publications, the direct method is applied to Salmonella and
Varicella-Zoster virus antibody data. This approach has not been applied to anal-
yse malaria serology data and, in this paper, we propose a modelling framework
that is inspired by Hens et al. [65].
In addition to the seroconversion rate, boosting rates, i.e. the rate at which anti-
body levels are acquired, can also be used as a marker for transmission intensity
[20, 30, 40]. Antibody aquisiton models (AAMs) have been developed as an alter-
native approach to RCMs, and do not involve the use of thresholds but instead rely
on the full antibody measurements in order to estimate boosting rates. However,
in the context of malaria serology, current formulations of the AAM assume that
the antibody measurements follow a log-Gaussian distribution, clearly an invalid
assumption in the case of a bi-modal distribution arising from the mixing of the
seropositive and seronegative populations [40].
RCMs and AAMs that have been applied to the analysis of malaria serology data
make strong assumptions on the temporal dynamics of transmission, which are
generally restricted to the following patterns: constant transmission; a sharp step-
wise drop in transmission; and a linear drop in transmission [20, 30, 32, 40]. The
validity of these assumptions is often questionable, and more flexible functional
forms for the variation of transmission over time have not been considered in the
context of malaria serology.
In this paper, we develop a unified mechanistic model for the analysis of malaria
serology data which combines the properties of mixture models, reversible catalytic
models, and antibody acquisition models in order to reliably estimate malaria
transmission intensity. We also show that the additional flexibility brought by this
novel model allows better description of temporal dynamics of malaria transmis-
sion. In addition to this, we present an alternative empirical approach to account
for the age-dependency of the antibody distributions and use this approach to
validate the unified mechanistic model.
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The structure of the paper is as follows. Section 3.2 provides an overview of
current models for malaria serology analysis. Section 3.3 introduces a unified
mechanistic model and outlines an alternative empirical approach that can be used
to analyse malaria serology data. In section 3.4 we apply this new framework to
cross-sectional antibody data from Western Kenya, and section 3.5 is a discussion
of the results. Finally section 3.6 provides a summary and conclusion.
3.2 Existing models
3.2.1 Mixture models
In the context of malaria and other infectious diseases, mixture models are de-
veloped under the assumption that the population of interest is indeed a mixture
of latent seropositive and seronegative populations [20, 66]. More formally, let Yi
denote the log-transformed antibody measurement for the i-th individual. Let S+
and S− be a shorthand notation for “seropositive” and “seronegative” classifica-
tions, respectively. Assuming independent and identically distributed realizations





(1− p)fS−(yi;µS− , σ2S−) + pfS+(yi;µS+ , σ2S+)
]
(3.1)
where fS+ is a univariate log-Gaussian distribution with mean µS+ and variance
σ2S+ for the S+ population, and analogously for S−; finally, p is the probability of
being S+.
Let Ci and C∗i denote the random variables representing classification based on
the mixture model and true classification of the i-th individual, respectively. One
approach is to define a seropositivity threshold, usually µS− + 3σS− , above which
Ci is S+, and S− if below [20, 32, 34, 64, 65]. An alternative, more elaborate,
approach is to first calculate the probability of belonging to group C∗i , conditional
on the antibody measurement Yi = yi, i.e.
P (C∗i = S+|yi) =
pfS+(yi; θS+)
(1− p)fS−(yi; θS−) + pfS+(yi; θS+)
(3.2)
P (C∗i = S−|yi) = 1− P (C∗i = S+|Yi = yi)
where θS− = (µS− , σ2S−) and θS+ = (µS+ , σ2S+).
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Based on two probability thresholds, c− and c+, the classification Ci is
Ci =

S− if P (C∗i = S−|Yi = yi) ≤ c−
I if c− < P (C∗i = S−|Yi = yi) < c+
S+ if P (C∗i = S+|Yi = yi) ≥ c+
, (3.3)
where I is an additional classification label introduced to denote inconclusive cases.
In serology analysis, a common approach is to exclude these cases, depending on
the type of disease, and report the proportion of inconclusive cases [64, 65, 67].
Figure 3.1: An illustration of the mixture model showing the bi-modal distributions
for the S− (red) and S+ (blue) populations. The dotted line in Figure (a) shows the
seropositivity threshold µS− + 3σS− , above which individuals are classified as S+. The
grey rectangle in Figure (b) shows the inconclusive cases as defined by equation 3.3. In
this case, the probability thresholds c− and c+ have been set to 90%. Individuals below
this grey region are classified as S−, while individuals above this region are classified as
S+. These data are taken from the Pf AMA1 analysis in section 3.4.
In malaria serology, most studies favour the first threshold-based approach that
does not introduce the classification for inconclusive cases [30, 32, 36, 40, 68, 69].
This is likely due to the nature of antibody responses to malaria infections which
result in a large proportion of ‘inconclusive’ cases, as reported by Sepúlveda et al.
[20].
However, both of these threshold-based approaches are prone to misclassification,
which can create bias in estimating epidemiological parameters [20, 64, 65]. Fur-
thermore, current applications of mixture models in malaria serology analysis do
not take into account the age-dependence of antibody levels, and assume that the
mixing of S+ and S− is the same across all ages, which may further exacerbate
the issue of misclassification.
The two component mixture Gaussian models also do not account for antibody
boosting upon re-exposure to malaria parasites. Sepúlveda et al. [20] present an
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extension to the traditional mixture model where more components are added in
order to account for this boosting effect. These components can be interpreted
as varying degrees of malaria exposure; unexposed, once exposed, twice exposed,











The number of components K is then treated as an additional parameter to esti-
mate using the profile likelihood. However, the interpretation of the components of
the model is problematic due to ambiguity about classification rules, particularly
when component means are close together. This approach also further compounds
the problem of inconclusive cases as they occur across multiple components.
3.2.2 Reversible catalytic models
Following the dichotomization of the continuous antibody measurements through
the application of a mixture model, the resulting S+ and S− outcomes are modelled
using a reversible catalytic model (RCM). A common assumption of the RCM is
that individuals are born S− and, after becoming S+ upon exposure to malaria, can
revert to S− in the absence of exposure. This mechanistic approach is illustrated
in Figure 3.2a. Since antibody data are assumed to represent the cumulative
exposure of individuals during their lifespan, the age of individual prior to the
sample collection is used as proxy for historical time.
Let λ(a) denote the seroconversion rate for an individual at age a and ω the
seroreversion rate. According to the RCM, the temporal dynamics that regulate




= λ(a)(1− p(a))− ωp(a). (3.5)
In the above equation, λ(a) is a measure of the underlying transmission intensity
which is associated with the gold standard indicator of transmission, the EIR
[25], while ω is typically fixed and assumed to be constant [20]. However, some
authors Bosomprah [32] and Akpogheneta et al. [70] suggest that ω may be age-
dependent. Sepúlveda et al. [20] argue that the malaria serology data often carry
little information in the estimation of ω, a problem which will persist also in
our novel modelling framework. Hence, throughout this paper, we shall make
the working assumption of a constant ω. Note that the reciprocals of λ and ω
estimates, i.e. 1/λ and 1/ω, indicate the estimated number of years within which
seroconversion and seroreversion would occur, respectively.
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Three transmission profiles have so far been proposed to model the seroconversion
rate λ(a). The simplest assumes a constant transmission, hence λ(a) = λ for all







In the equation above, the proportion of S+ at older ages reaches a maximum
value of about λ/(λ+ ω). In other words, in a cohort of an initially malaria naive
population, p(a) will ultimately reach a plateau at which the number of individu-
als seroconverting is the same as the number of individuals seroreverting [20, 25].
However, these assumptions may be too stringent as they ignore changes in trans-
mission that may be due, for example, to the introduction of control interventions
[20, 34, 66].
To tackle this issue, one approach is to assume a transmission profile with a sharp
drop in transmission at the time of intervention. In this model, two transmission
rates are estimated: λ1 and λ2 which represent the transmission rates before and
after the drop, respectively. An alternative approach to account for control inter-
ventions, is to assume a linear reduction in the seroconversion rate λ(a), rather
than a step-change as we have just illustrated. However, in this case, the differen-
tial equation in (3.5) cannot be solved analytically and numerical procedures must
instead be used.
In the study by Yman et al. [40], the two transmission profiles that do not as-
sume a constant λ(a) provide a better fit to the data. However, assumption of
a step-change or linear drop in λ(a) may be inappropriate in presence of major
or prolonged malaria outbreaks within the historical time-frame considered. In
general, the validity of any of these profiles is dependent on a variety of factors,
including intervention history, climate and vector characteristics. More recently,
Varela et al. [42] propose a model where the number of times that λ changed in
the past, is also estimated from the data.
Where seropositivity is defined using the traditional two-component Gaussian mix-
ture model, there is still the issue of how to account for antibody boosting due
to repeated exposure to malaria parasites. Bosomprah [32] suggests an extension
to the RCM, which involves creating more seropositive classes in a superinfec-
tion model (SIM), similar to the multi-component mixture model described by
Sepúlveda et al. [20]. In this framework, a seronegative individual can transition
to the first seropositive class, S+, upon first exposure, and subsequently to a higher
seropositive class S++ upon re-exposure, and so on, as illustrated in Figure 3.2b.
The SIM also faces challenges with interpretation of results where initial exposure
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and boosting between the multiple seropositive classes may be conflated [20, 21].
Figure 3.2: (a) is a representation of the reversible catalytic model (RCM) where
individuals transition between seronegative (S−) and seropositive (S+) states through
the SCR, λ(a) and the SRR, ω. (b) is a representation of the superinfection model
(SIM) where individuals can have their antibodies ‘boosted’ through increasing
seropositive (S+...) states depending on the cumulative exposure to malaria parasites.
3.2.3 Antibody acquisition models
An alternative modelling approach to estimate transmission intensity is to use
antibody acquisition models (AAMs) [30, 40]. Unlike RCMs, AMMs use the full
antibody measurements without requiring any dichotomization of the data. More
specifically, AAMs are used to estimate the boosting rate, i.e. the rate at which
antibodies are acquired, a marker for transmission intensity [20, 30, 31, 40]. Let
µ(a) denote the average antibody level in the general population of individuals of
age a. Assuming that following exposure to parasites, µ(a) is boosted at a rate
γ(a) and assuming a constant decay rate r, we can express this mechanism through
the following differential equation
dµ
da
= γ(a)− rµ(a). (3.7)
We can then use the above equation to infer changes in average antibody levels as
a function of age a. Finally, in order to fit (3.7) using likelihood-based methods
of inference, the antibody levels of individuals at age a are assumed to follow a
log-Gaussian distribution with mean µ(a) and variance σ2 [20, 30, 40].
Similar to the way seroconversion rates have been modelled in RCMs (section
3.2.2), previous studies have considered three transmission profiles for the speci-
fication of γ(a). The simplest approach assumes that γ(a) = γ is constant which
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Similarly to RCMs, extensions of the AAM assumes either a step-change or linear
reduction in the boosting rate γ ; see Sepúlveda et al. [20], Weber et al. [30], and
Yman et al. [40] for more details.
Direct comparison of γ and λ from the AAM and RCM, respectively, may not be
possible as these estimate different serological indicators. However Yman et al.
[40] finds that the AAMs provide a more consistent fit to age-dependent antibody
data compared to RCM fit to age-dependent seroprevalence data, particularly in
the estimation of the change point (i.e when there was a change in transmission).
Additionally, AAMs provide better precision in parameter estimation and appear
to be more robust to sample size reduction. It has been found that AMMs often
provide a good fit to serological data in high to moderate transmission settings,
where a large proportion of individuals may be seropositive [40], or where an
antigen is highly immunogenic, leading to high seropositivity to its antibody in
the population [30].
3.3 A unified mechanistic model for the analysis
of malaria serology data
In this section we develop a statistical modelling framework which extends the
standard mixture model outlined in section 3.2.1 to incorporate both the RCM
and AAM dynamics and provides a more flexible approach to model time changes
in the seroconversion rate and boosting rate. In this unified framework, the mix-
ing probabilities - i.e. probability of belonging to the S+ and S− populations -
are modelled based on the RCM, while the means of the two latent S+ and S−
distributions are informed by AAM dynamics.
To avoid the need of solving complex differential equations, we re-express (3.5)
with a discrete-time difference equation, i.e.
p(a)− p(a− 1) = λ(a)(1− p(a))− ωp(a)
or, equivalently,
p(a) = λ(a) + p(a− 1)1 + λ(a) + ω .






k=h(1 + λ(h− k) + ω)
(3.9)
This allows us to specify any function for λ(a) without being constrained to three
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options described in section 3.2.2. The above describes the proportion of S+
individuals who are aged a, p(a), as a weighted sum of transmission intensities
occurring in all the years since birth, λ(h), with weights decreasing exponentially
as we move further back in time from the time of data collection.
We apply this same idea to the AAM, allowing for temporally varying γ(a). More
specifically, by using a discrete-time dynamic we re-write (3.7) as
µ(a)− µ(a− 1) = γ(a)− rµ(a)
or, equivalently,
µ(a) = 11 + r
(
γ(a) + µ(a− 1)
)
.










Similar to the interpretation of (3.9), in this expression, the mean antibody level
at age a, µ(a), is given by weighted sum of all the boosting rates since birth, γ(h),
and the weights given are exponentially decaying. The assumptions of λ(0) = 0
and γ(0) = 0 may not be strictly valid, however, this is a pragmatic choice since
the true boosting and seroconversion rates at birth are not known but are expected
to be close to zero on account of underdeveloped immune responses to malaria in
infants who rely on maternal antibodies up to 9 months after birth [14, 31, 71].
To model the temporal changes in λ(h) and γ(h), in absence of a detailed informa-
tion on intervention history, a pragmatic approach is to use a log-linear regression
in the years before the time of data collection, which is expressed as
λ(h) = exp{l0 + l1(a− h)}
γ(h) = exp{g0 + g1(a− h)} (3.11)
where h corresponds to a given age of an individual before the time of collection
and, thus, a − h is the years before the time of data collection. Finally, l0, l1,
g0 and g1 are regression parameters to estimate (Figure S1 of the supplementary
material further illustrates the mechanism of this approach).
Assuming µ(ai) in (3.10) to be the mean level of antibodies in the S− population,
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where δ > 1 is a multiplicative factor accounting for the higher mean levels of
antibodies in the S+ population. Note that the seronegative distribution is also
modelled as age-dependent to account for potential residual antibody levels due to
previous infections. In the ‘direct’ approach, we utilize the underlying structure of
the mixture distribution in order to estimate transmission parameters in the unified
mechanistic model, thus avoiding dichotomization of the antibody measurements
while accounting for age dependency of the mean and probabilities of the mixture.
The resulting structure of the unified mechanistic model is summarised in Figure
3.3(a).
When analysing cross-sectional data, estimation of the model in (3.12) can be
problematic because of the large number of parameters to estimate. In absence of
a large amount of data, the approach we follow in this paper is to consider two
models, one assuming a time-varying seroconversion rate and a constant boosting
rate, and a second where the reverse is assumed. Comparison between the two
models is then carried out based on a goodness-of-fit index, such as the Akaike
Information Criterion (AIC). The AIC is defined as 2p − 2 log(L̂), where p is the
number of parameters in the model and L̂ is the value of the likelihood function
evaluated at the maximum likelihood estimate. The AIC is used to quantify the
goodness of fit of a model to the data while penalizing models that contain a
larger number of parameters. The AIC can be used to compare models that are
not nested, i.e. models that are not contained within each other. A lower AIC
usually indicates a better fit to the data.
Another simplification that we introduce in the maximization of the likelihood
function is to fix the seroreversion rate ω. In practice, we found that using nu-
merical optimization with a continuous ω was unstable as a result of a very flat
likelihood surfaces. Maximization of the likelihood estimation is carried through
unconstrained optimization using PORT routines as implemented in the “nlminb”
function in R
3.3.1 Alternative empirical approaches to model age-dependency
When the interest is in describing the effect of age on the distribution of antibody
data, an empirical, rather than mechanistic approach, may provide a better sta-
tistical solution. Additionally, the empirical approach outlined in this section can
be used to validate the unified mechanistic model by assessing the discrepancy
between the age distributions generated by the two modelling approaches.
To this end, we modify the framework introduced in the previous section by re-
placing the modelling of mixing probability based on RCMs, and the mean level of
antibodies based on AAMs, with their empirical counterparts. More specifically,
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Figure 3.3: (a) is a representation of the unified mechanistic model, showing how the
reversible catalytic model and antibody acquisition model are incorporated into the
mixture model for antibody data. (b) is a representation of the empirical model used
to model age-dependence in the mixing probabilities and mean antibody level.
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= α1 + f1(a)
log{µ(a)} = α2 + f2(a) (3.13)
where f1(a) and f2(a) are functions which can be specified with the aid of simple
graphical tools, such as scatter plots. The resulting structure of the empirical
model is summarized in Figure 3.3b, and we give examples of this in the application
of section 3.4.
3.4 Analysis of malaria serology data from West-
ern Kenya
We analyse data collected from a cross-sectional survey conducted in Rachuonyo
South District, in the western Kenyan highlands, in 2011. At the time, malaria
transmission in Rachuonyo South was described as generally low but highly het-
erogeneous, with an average of 14.8% malaria prevalence [72]. Transmission was
characterized as seasonal, following peaks in rainfall, typically between March-June
and October-November [72, 73].
Most malaria was attributed to Pf, with predominant vector species being Anophe-
les gambiae s.s., A. arabiensis, and A. funestus [74, 75]. Malaria control inter-
ventions at the time included distribution of long-lasting Insecticide-treated nets
(LLINs) which had been ongoing for many years, and Indoor Residual Spraying
(IRS) which started in 2009 [75]. Further details of the study design and data
collection can be found in Bousema et al. [72, 75]
In the study, finger prick blood was collected from all participants on filter paper
and used to detect total Immunoglobulin G (IgG) antibodies against the blood-
stage Pf antigen apical membrane antigen 1 (Pf AMA1) using the Enzyme-linked
immunoassay (ELISA). Optical density (OD) values were obtained for this antigen
and are the outcome that we model in this analysis, which we restrict to individuals
between 1 and 16 years of age. Children under 1 year old are excluded from the
analysis due to the effect of maternal antibodies, which are present at birth, and
are believed to wane between 6-9 months[26, 40, 76]. The upper age range of 16
years is selected to exclude older individuals whose antibody levels may exhibit
a noisier distribution and thus hinder the ability of the model to detect changes
in transmission in the recent past from the time of data collection [40]. The
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noisier distribution in older individuals may result from an accumulation of factors
which increase the variation in antibody responses to malaria in the long-term,
for example individuals’ nutrition history, migration between regions of different
endemicity, varying histories of intervention use, e.t.c.
The data-set consists of n = 9549 children. Figure 3.4 shows the age and OD
distributions of the individuals included in the analyses.
Figure 3.4: Descriptive plots of the age distribution (a) and the log OD distribution
(b) of individuals aged 1-16, who are included in the Pf AMA1 antibody analysis.
We fit both unified mechanistic and empirical models to the Pf AMA1 antibody
data using the maximum likelihood method of estimation. Maximum likelihood
estimation is facilitated by unconstrained and box-constrained optimization using
PORT routines through the nlminb function in R. The full reproducible code is
available on GitHub (see ‘Data availability’.
To obtain 95% confidence intervals (CIs) for the model parameters estimates, we
use parametric bootstrap. In this procedure, parameter estimates from the respec-
tive models are used to generate 1000 replicate datasets. For each of the datasets,
we refit the model and re-extract the parameter estimates in order to construct the
bootstrap distribution, and therefore the CIs. We also account for the truncated
nature of the antibody distributions, due the exclusion of individuals under age 1
and over age 16, by using truncated log-Gaussian distributions. The upper limit
of the truncation is estimated for each age group as the maximum observed value
of OD.
Based on the comparison between the AIC values (see Table 2 in the supplemen-
tary material), preliminary analysis of the Pf AMA1 data shows that a unified
mechanistic model that assumes a time-varying seroconversion rate λ(a) and a
constant boosting rate γ provides a better fit to the data than a model where
the reverse assumptions is made (i.e. constant λ and time varying γ(a)). We let
ω take three values, namely 0.01, 0.5 and 1, hence assuming that seroreversion
events among individuals would occur between 1 and 100 years [25, 26, 70]. In
what follows, we present results for the best performing value for ω, i.e. ω = 0.01.
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To summarize, the unified mechanistic model parameters to estimate via maximum
likelihood are the following: l0 and l1 which are related to the seroconversion rate
λ as described by (3.9) and (3.11); boosting rate γ and decay rate r from (3.10);
and the mixture distribution parameters δ, σ2S− , and σ2S+ from (3.12).
Figure 3.5: Exploratory analysis of the Rachuonyo South District Pf AMA1 antibody
data. (a) shows the geometric mean OD across age while (b) shows the proportions of
S+ individuals, p, as defined by (3.1), using the seropositivity threshold (i.e.
µS− + 3σS−). The circle sizes in (b) are proportional to the sample size in each age
group.
For the empirical model, µ(a) and the mixing probability are modelled according
to (3.13), and are informed by Figure 3.5. We apply a linear spline with a knot at
age 10, based on the empirical trend for µ(a) observed in Figure 3.5a, to give
µ(a) = exp{β1 + β2a+ β3(a− 10)I(a > 10)}, (3.14)
where I(a > 10) is an indicator function that takes value 1 if a > 10, and 0
otherwise. Based on Figure 3.5b, we introduce the log-transformed age as a logit-
linear predictor for p(a), such that
p(a) = exp{β̃0 + β̃1 log a}
1 + exp{β̃0 + β̃1 log a}
(3.15)
Thus, the model parameters to estimate for the empirical model are: the regression
coefficients β1, β2, and β3 in (3.14), and β̃0 and β̃1 in (3.15); and, as in the unified
model, δ, σ2S− , and σ2S+ .
Results of this analysis indicate strong evidence of age-dependency for the mixing
probabilities of Pf AMA1. Figure 3.6 shows a bi-modal antibody distribution be-
tween ages 5 to 10, which is less evident in younger and older individuals. Both the
empirical and mechanistic models are able to capture the increase in the means of
antibodies for the S+ and S− distributions, with younger children having generally
lower antibody levels than older individuals.
By comparing the fitted density functions of mixture distributions between the
mechanistic and empirical models for Pf AMA1 (Figure 3.6), we notice that, while
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Figure 3.6: Age-dependent mixture distributions of Pf AMA1 antibodies for
individuals 1 to 16 years of age in Rachuonyo South District. The red line indicates
distributions derived from the unified mechanistic model, while the blue dotted line
indicates distributions derived from the alternative empirical model.
there is a general agreement between the two models, there are visible discrepancies
at certain ages. These are more evident in very young individuals at age 1, and in
older children from around age 8 onward, where the empirical model indicates a
more noticeable peak for the S− distribution.
Finally, the estimates for δ and σ2s+ from the unified mechanistic and empirical
models are comparable, with largely overlapping 95% confidence intervals (Table
3.1).
With regards to λ(h), Figure 3.7 shows the estimated changes in this parameter in
the 16 years before data collection. The results indicate a decrease in transmission
in recent years.
Finally, based on the AIC, we note that the unified mechanistic model is larger,
suggesting that inferences from the mechanistic model should be drawn with cau-
tion. This is because the mechanistic model may not provide an equally good
description of the antibody distribution across all ages as shown by the discrepan-
cies between the red and blue lines of Figure 3.6. However, because the differences
between the models are not substantial, we believe that the unified mechanistic
model does provide useful insights into time variations of the seroconversion and
boosting rates, for which the empirical model does not provide any information.
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Figure 3.7: Changes in λ over historical time as derived from the unified mechanistic
model fitted to Pf AMA1 antibody data. The blue lines indicate 95% CIs. ‘Years ago’
corresponds to (a− h) as described in (3.11).
Table 3.1: Maximum likelihood estimates with associated 95% CIs (within brackets)
for the unified mechanistic model (UFM) and empirical model (EM), fitted to the
Pf AMA1 antibody data. The Akaike Information Criterion (AIC) is also reported.
equation parameter UFM EM
eq 3.9 and 3.11 l0 -2.696 (-2.627, -2.397)
l1 0.246 (0.202, 0.264)
eq 3.10 γ -1.5 (-1.687, -1.291)
r 3.806 (3.122, 4.754)
eq 3.12
δ 31.086 (27.637, 37.837) 28.348 (25.265, 34.197)
σ2s− 2.506 · 10−3(2.169 · 10−3,2.914 · 10−3) 1.895 · 10−3(1.613 · 10−3,2.288 · 10−3)
σ2s+ 23.977 (15.783, 46.364) 36.063 (23.244, 70.104)
eq 3.14
β1 -3.141 (-3.191, -3.087)
β2 0.052 (0.046, 0.058)
β3 -0.021 (-0.032, -0.005)
eq 3.15 β̃0 -3.031 (-3.194, -2.69)
β̃1 2.005 (1.915, 2.188)
AIC 29791.910 29711.460
3.5 Discussion
We have introduced a unified mechanistic model which 1) avoids the dichotomiza-
tion of continuous antibody data and 2) provides a more flexible way for modelling
antibody distributions while allowing for the joint estimation of seroconversion and
boosting rates, namely λ(a) and γ(a), respectively.
The additional flexibility is obtained by modelling the age-dependency of antibody
distributions and the temporal variations in λ(a) and γ(a) which are informed by
the reversible catalytic model (RCM) and antibody acquisition model (AAM), re-
spectively. The disadvantages of dichotomizing continuous data into binary data, a
common practice in the standard use of RCMs, are well established. Dichotomiza-
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tion can lead to the loss of information which affects the ability to reliably recover
regression relationships and the precision of parameter estimates [3–6, 77]. The
proposed unified modelling framework in this paper avoids this problem by making
use of the full continuous antibody distribution.
As an alternative approach to the mechanistic framework, we have proposed the
use of an empirical approach where the age dependency is informed by the data
rather than by biological assumptions. The choice between the unified and empiri-
cal models may depend on the research context. The mechanistic approach allows
for the estimation of λ(a) and γ(a) that may be of intrinsic scientific interests,
whilst the empirical model does not provide any information on these. Therefore
where the interest is in estimating λ(a) and γ(a), the unified mechanistic model is
preferable, however when the interest is simply in describing the age dependency
of the mixture model, or estimating seroprevalence, then the empirical model is
preferable as it is more parsimonious. In our application, the empirical model pro-
vided a better fit to and, hence a better description of, the antibody distributions
for different ages, although the discrepancies between the fitted antibody distri-
butions of the empirical and unified models, as shown in Figure 3.6 were small for
most ages.
One of the main issues of the proposed unified modelling framework is that it re-
quires a large amount of data in order to reliably estimate the model parameters.
In cases where the separation between the seronegative and seropositive popula-
tions is weak, this may result in very uncertain estimates. For example additional
analysis of the antigen PfMSP119 showed limited evidence of a bi-modal distri-
bution or age dependency in the mixture distribution, making the estimation of
the proposed model unfeasible. More generally, mixture models may be difficult
to estimate, especially in areas of high transmission where a great majority the
population is seropositive [21, 40]. Additionally, the seroreversion rate ω may also
difficult to estimate in this scenario and, for this reason, is often fixed[20]. This
is one of the main limitations in reversible catalytic models, which also applies
to the unified mechanistic model. Generally, to alleviate the problem of over-
parametrization, further simplification of the model may be considered by, for
example, assuming a constant λ(a). In such scenarios, however, we believe selec-
tion between models should also be guided by scientific, a not purely statistical,
judgement, while also taking into consideration the levels uncertainty inherent to
each model.
More complex functional forms for modelling time-changes in λ(a) and γ(a) than a
log-linear regression, as used in this paper, could also be considered. For example,
polynomials and smoothing splines would be a natural choice to increase the flex-
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ibility of the model. Alternatively, contextual knowledge on events that may have
significantly impacted transmission in the past, such as interventions and malaria
outbreak, may also be used to inform the modelling of λ(a) and γ(a). However,
the increased flexibility comes at the cost of an increased model complexity which
may make the model very difficult, if not impossible, to estimate.
3.6 Conclusion
We have proposed a unified modelling framework for the analysis of malaria serol-
ogy data which allows for the joint estimation of seroconversion and boosting
rates. Our framework makes the best possible use of the data by avoiding the
dichotomization of the continuous antibody measurements, a common practice in
the analysis of malaria serology data. More importantly, the unified framework
allows us to critically assess and evaluate assumptions on the heterogeneity of
biological indicators of malaria transmission using a principled likelihood-based
framework.
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Summary
In malaria serology analysis, the standard approach to obtain seropreva-
lence, i.e the proportion of seropositive individuals in a population, is based
on a threshold which is used to classify individuals as seropositive or seroneg-
ative. We argue that the choice of this threshold is often arbitrary and is
based on methods that ignore the age-dependency of the antibody distribu-
tion. Using cross-sectional antibody data from the Western Kenyan High-
lands, we introduce a novel approach that has three main advantages over
the current threshold-based approach: it avoids the use of thresholds; it ac-
counts for the age dependency of malaria antibodies; and it allows us to prop-
agate the uncertainty from the classification of individuals into seropositive
and seronegative when estimating seroprevalence. The reversible catalytic
model is used as an example for illustrating how to propagate this uncer-
tainty into the parameter estimates of the model. We find that accounting
for age-dependency leads to a better fit to the data than the standard ap-
proach which uses a single threshold across all ages. Additionally, we also
find that the proposed threshold-free approach is more robust against the
selection of different age-groups when estimating seroprevalence. The novel
threshold-free approach presented in this paper provides a statistically prin-
cipled and more objective approach to estimating malaria seroprevalence.
The introduced statistical framework also provides a means to compare re-
sults across studies which may use different age ranges for the estimation of
seroprevalence.
Keywords: malaria serology; geostatistical model; reversible catalytic model;
antibody acquisition model; unified mechanistic model.
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4.1 Introduction
Thanks to increased diagnostic capacity, preventative measures and a scale-up of
interventions, there has been an overall decrease in malaria burden worldwide [78,
79]. However, malaria still remains a significant global public health threat in sub-
Saharan Africa, where Plasmodium falciparum (Pf) is the predominant parasite.
A total 229 million cases and 409,000 deaths have been estimated globally in 2019
[80]. Additionally, the decrease in malaria is heterogeneous across regions, coun-
tries and communities [79–83], posing additional challenges to malaria elimination
efforts. These challenges require robust surveillance mechanisms which can adapt
to the changing epidemiology, enabling a more targeted approach to intervention
strategies [81, 84].
To estimate malaria exposure and transmission, analysis of human serology data
has emerged as a viable alternative approach to disease risk metrics that are based
on the detection of malaria parasites in humans and mosquito populations [20, 25,
40]. Because of the persistence of antibodies after infection, their concentration is
less influenced by the seasonality of transmission and can be used as an indicator
of the cumulative exposure to malaria. Additionally, antibodies, unlike the Plas-
modium parasite, can be easily detected even in low transmission areas [21, 25, 26,
28].
Analysis of seroprevalence - i.e the proportion of ‘seropositive’ individuals - is often
carried out using reversible catalytic models (RCM). These models allow for the
estimation of seroconversion rates which quantify the transmission intensity and
correspond to the rate at which individuals convert from seronegative to seropos-
itive through exposure to malaria parasites over time [20, 25]. Alternatively, con-
tinuous antibody measurements can be used in antibody acquisition models to
estimate boosting rates, another measure of transmission intensity, which repre-
sents the rate at which antibodies are boosted upon exposure to parasites [20, 40,
85]. Such indicators of transmission intensity can be used to inform decisions on
intervention strategies by identifying hot-spots of transmission where individuals
are likely to exceed a specified degree of exposure [73, 86].
To estimate seroprevalence, classification of individuals as seropositive or seroneg-
ative is required. The most commonly used approach is to identify a suitable
threshold of antibody density beyond which individuals are classified as seropos-
itive, and below as seronegative [20, 25, 26]. To this end, mixture distributions
are first fitted to the antibody density data, assuming that continuous antibody
measurements consists of two latent distributions, one for the seronegative and
one for the seropositive populations. By using the point estimates of the mean,
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µS− and standard deviation, σS−, of the seronegative distribution S−, the seropos-
itivity threshold is often set to µ + 3σ [20, 32, 34, 35], while other studies have
instead used µ+2σ [36–38]. An alternative to this approach is to define thresholds
based on the predictive probability of being seropositive resulting from the fitted
mixture distribution [20].
The major drawback of threshold-based approaches is that the choice of the thresh-
old is arbitrary and it is unclear to what extent this affects the results of the statis-
tical analysis of serological data, as biased estimates of seroprevalence can in fact
arise from the misclassification of individuals as seronegative or seropositive [64].
Additionally, in the case of the probability thresholds, individuals whose probabil-
ity of belonging to either the seronegative or seropositive groups is close to 50% are
often classified as ‘intermediate’, and are therefore excluded from analysis [20, 64].
Furthermore, the uncertainty around the estimated thresholds and probabilities
used for the classification of individuals, is ignored.
In addition to these drawbacks, classical analysis of malaria serology data does
not account for the age dependency of antibody distribution when calculating
thresholds. Typically in mixture models, a threshold is obtained by assuming a
constant mixing probability across all ages [85]. This assumption is questionable
since, in malaria endemic settings, it is well known that antibody levels are in fact
age-dependent [87, 88] and thus the likeihood of being seropositive is expected
to increase with age. A 2011 study by Ster [89] incorporated age-dependency
for varicella zoster virus serology mixture models, however to our knowledge, this
principle has not been applied to malaria serology data
To address these issues, Kyomuhangi et al. [85] proposed a unified modelling frame-
work for the analysis of malaria serology data that uses the continuous antibody
measurement rather than thresholds to estimate transmission parameters. How-
ever, as acknowledged by the authors, this modelling framework requires a larger
amount of data than is usually available in serological studies to reliably estimate
all the model parameters, thus limiting its applicability.
In this paper, we propose a novel modelling approach for the analysis of serological
data that retains the same properties of the approach proposed in Kyomuhangi
et al. [85], but is also more parsimonious. More specifically, our novel approach
satisfies the following requirements: 1) it accounts for age dependency of antibody
levels; 2) it avoids the use of any threshold; and 3) it allows us to account for and
propagate the uncertainty in the classification of seropositive and seronegative indi-
viduals. Using cross-sectional antibody data from Western Kenya, we demonstrate
1) the properties of this new methodology for estimating malaria seroprevalence,
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and 2) how to incorporate the uncertainty around the resulting seroprevalence es-
timates, using the standard RCM as an example. In the discussion, we explain
how the principles used to develop this novel approach can be extended to more
complex analysis of serological data.
Methods
Existing methods for estimating seroprevalence
Here, we outline the most commonly used methods in the analysis of malaria
serology data, to classify individuals as seropositive and seronegative, using a two-
component mixture distribution.
Let Yi denote the log-transformed antibody measurement for the i-th individual in
a sample, S− denote the seronegative classification, and S+ denote the seropositive
classification. Assuming independent and identically distributed realizations for
a sample of n individuals, and µ to be the mean level of antibodies in the S−





(1− p)fS−(yi;µ, σ2S−) + pfS+(yi; δµ, σ2S+)
]
(4.1)
where fS− is a univariate log-normal distribution with mean µ and variance σ2S−
for the S− population, and analogously for S+, with δ > 1 being a multiplica-
tive factor accounting for higher mean antibodies in the S+ distribution. p is the
probability of being S+. Let Ci and C∗i denote the random variables representing
classification based on the mixture model and true classification of the i-th indi-
vidual, respectively. Based on the seropositivity threshold κ, the classification of
individuals, say Ci, into S+ and S− is defined as
Ci =
S
− if Yi < κ
S+ if Yi ≥ κ
. (4.2)
In our application, we shall use κ = µS− + 3σS− , as this is used in most other
statistical analyses of malaria serology data.
Proposed method for estimating seroprevalence
We propose a novel modelling framework that overcomes the limits of the approach
described in the previous section, by incorporating age-dependency into the mix-
ture distribution in (4.1), and by propagating the uncertainty in the classification
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of individuals into S+ and S− using a Monte Carlo approach.
In this framework, age dependency is introduced into (4.1) using linear regression,
as described in Kyomuhangi et al. [85]. Assuming µ(ai) to be the mean level of





(1− p(ai))fS−(yi;µ(ai), σ2S−) + p(ai)fS+(yi; δµ(ai), σ2S+)
]
(4.3)
where p(ai) is the probability of being S+ at age a. Note that the seronegative
distribution is also modelled as age-dependent to account for potential residual
antibody levels due to previous infection. The age dependencies in p(a) and µ(a)






= α1 + g1(a)
log{µ(a)} = α2 + g2(a) (4.4)
where g2(a) is a function of age that can be specified through empirical inspection
of the data. In the case of g1(a), identifying a suitable specification may be more
problematic because of the need to dichotomize the data. However, because it is
well established that p(a) increases for increasing a, a pragmatic approach would
be, for example, to specify a logit-linear regression on a as illustrated later in this
paper. Note that predictor for these models can take other functional forms such
as polynomials and smoothing splines to increase their flexibility.
Using the resulting mixture distribution, we compute the predictive probability of
belonging to the S+ distribution for each sampled individual, by conditioning on
the observed antibody measurement Yi = yi and age ai, to give
P (C∗i = S+|yi, ai) =
p(ai)fS+(yi; θS+)
(1− p(ai))fS−(yi; θS−) + p(ai)fS+(yi; θS+)
(4.5)
P (C∗i = S−|yi, ai) = 1− P (C∗i = S+|Yi = yi, ai)
where θS− = (µ(ai), σ2S−) and θS+ = (δµ(ai), σ2S+). Based on the above expressions,
when then simulate 10,000 classifications C∗i for a every single sampled individual.
The resulting 10,000 data-sets generated from this process are then fed into the
second stage of the analysis, which we explain in the next section.
We point out two main advantages of this modelling approach. The first is that
it avoids the use of a threshold κ as in (4.2) and uses the generated samples Ci to
propagate the uncertainty of the classification into S+ and S−. The second is that
the empirical approach used to account the age-dependency combines information
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across all ages as described in (4.4), and is therefore more efficient than fitting
separate mixtures distribution for each age.
The structure of this modeling framework is illustrated in Figure 4.1.
Figure 4.1: An illustration of the empirical model introduced in Kyomuhangi et al.
[85].This model is used to describe the antibody mixture distribution as indicated in
equations (4.3) and (4.4)
The reversible catalytic model
The RCM assumes that individuals are born S− and, after becoming S+ upon
exposure to malaria, can revert to S− in the absence of exposure. Since antibody
data are believed to represent the cumulative exposure of individuals during their
lifetime, an individual’s age prior to the sample collection is used as proxy for
historical time.
Let λ(a) denote the seroconversion rate for an individual at age a and ω the
seroreversion rate. According to the RCM, the temporal dynamics that regulate




= λ(a)(1− p(a))− ωp(a). (4.6)
The seroconversion rate λ(a) can be modelled using a variety of approaches, the
simplest of which assumes constant transmission, i.e. λ(a) = λ for all a. Due to
poor identifiability of the seroreversion rate ω, this is typically fixed and assumed
to be constant across ages [20, 40, 42, 85]. Assuming a constant λ and ω in (4.6)
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More flexible models could also be used to account for the temporal variation
in λ, including a step-wise reduction or linear reduction in transmission [20, 42].
Additionally, other specifications of the RCM, for example the superinfection RCM
[32] could be applied in the proposed approach. However, in this paper, we restrict
our attention to the RCM defined in the above equation for simplicity, as we
compare existing methods and the proposed approach described in the previous
sections.
In order to propagate the uncertainty in classification of individuals as S+ and S−,
for the purpose of estimating parameters of the RCM, we maximize the likelihood
of a Binomial distribution with probability p(a), as indicated in (4.7), for each of
the 10,000 data-sets for the outcome Ci as described in the previous sections. This
gives 10,000 different estimates for λ, which we summarize by taking their mean
and 2.5% and 97.5% quantiles.
The estimation of the model parameters is conducted using the maximum like-
lihood estimation method. Let zi denote the binary variable indicating seropos-
itivity (zi = 1) or seronegativity (zi = 0) for the i-th individual; the likelihood





We analyse data from cross-sectional survey which was conducted in Rachuonyo
South District (34.75 to 34.95°E, 0.41 to 0.52°S), in the western Kenyan highlands
(1400 m to 1600 m altitude), in 2011 over a 100 km2 area. This survey was
the baseline for a cluster-randomized controlled trial whose aim was to determine
the community effect of interventions targeted at malaria prevalence hotspots.
Further details of the study protocol can be found in Bousema et al. [72] At the
time of the survey, malaria transmission in this area was described as low but
highly heterogeneous, and seasonal, following peaks in rainfall, typically between
March-June and October-November [72, 73].
The majority of malaria cases were attributed to Pf, with Anopheles gambiae s.s.,
A. arabiensis, and A. funestus being the predominant vector species. Malaria
control interventions at the time included distribution of Insecticide-treated nets
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which had been ongoing for many years, and Indoor Residual Spraying which
started in 2009[74, 75].
To generate the serology data, finger prick blood samples were collected from par-
ticipants on filter paper and used to detect total Immunoglobulin G (IgG) antibod-
ies against the blood-stage Pf antigens, apical membrane antigen 1 (Pf AMA1) and
merozoite surface protein-119 (Pf MSP119). Standard Enzyme-linked immunoassay
(ELISA) methods [26, 90] were used to obtain Optical density (OD) values. Fur-
ther details of the study design and data collection can be found in Bousema et al.
[72].
We first restrict analysis to individuals between 1 and 16 years. Additional analysis
on 1-20 year olds, 1-30 year olds, and 1-50 year olds is presented in the supple-
mentary material. We split the data this way in order to investigate the effect of
selecting different age-groups on the performance of M1 and M2. In what follows,
we shall first focus in the 1-16 year old age group.
The data-set consists of n = 9549 children for the Pf AMA1 analysis and n = 9576
for the Pf MSP119 analysis. Figure 4.2 shows the age and OD distributions of the
individuals included in the analyses.
Specifications of the model components
In this analysis, we compare two modelling approaches in the estimation of sero-
conversion rates, for both Pf AMA1 and Pf MSP119.
The first, which we refer to as M1, is the classic threshold-based approach as de-
fined in (4.1), which considers seropositivity according to (4.2). After dichotomiza-
tion of the antibody measurements, the RCM, as described by (4.6), is fitted using
the maximum likelihood method.
The second modelling approach, which we refer to as M2, is the proposed threshold-
free approach described in the previous sections. For this analysis, the age-
dependency of the mixture models for the two antigens is modelled using a an
empirical approach. Based on the Figure 4.3(a) for Pf AMA1, we use a linear
spline with a knot at the age of 10 years, formally expressed as
µ(a) = exp{β0 + β1a+ β2(a− 10)I(a > 10)}, (4.8)
where I(a > 10) is an indicator function that takes value 1 if a > 10, and 0
otherwise. For Pf MSP119, based on the trend observed in Figure 4.3(b), we use
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log-linear model, given by
µ(a) = exp{β0 + β1a}. (4.9)
To account for the age dependency in p(a), we introduce age as a logit-linear
predictor of p(a), i.e.
p(a) = exp{β̃0 + β̃1a}
1 + exp{β̃0 + β̃1a}
. (4.10)
Note that M1 is recovered when all the regression parameters except β0 and β̃0 in
(4.8), (4.9) and (4.10) are set to 0. Therefore for M1, we will report the estimates
for β0 and β̃0 only.
Figure 4.2: Descriptive plots of Pf AMA1 and Pf MSP119 antibodies for individuals
between ages 1 and 16. The top row shows the age distribution, the bottom row shows
the log OD distribution of individuals included in the analysis
For both M1 and M2, due to the truncated nature of the antibody distributions,
we use truncated log-normal distributions for both antigens. The upper limit,
say ymax(ai) of the truncation is estimated for each age group as the maximum
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Figure 4.3: Exploratory analysis of Pf AMA1 and Pf MSP119 antibodies for
individuals between ages 1 and 16. The figure shows the geometric mean OD by age,
with associated error bars




[(1− p(ai))fS−(yi;µ(ai), σ2S−) + p(ai)fS+(yi; δµ(ai), σ2S+)]
[(1− p(ai))FS−(ymax;µ(ai), σ2S−) + p(ai)FS+(ymax; δµ(ai), σ2S+)]
,
(4.11)
where FS+ and FS− are the cumulative distribution functions of seropositive and
seronegative probability distributions, respectively.
Finally, for the RCM, we considered a range of values from 0.01 to 1 for ω hence
assuming that seroreversion events for individuals would occur between 1 and
100 years [25, 26, 70, 86]. Profile likelihood analysis indicated flat likelihood
surfaces (see Figure S2), therefore we let ω take three values, namely 0.01, 0.5 and
1 to represent low, medium and high seroconversion rate respectively. In what
follows, we present results for the best performing value of ω for each antigen, i.e.
ω = 0.01 for Pf AMA1 and ω = 1 for Pf MSP119. Note that these values are not
the maximum likelihood estimates for ω, but rather the best performing values
out of the three choices stated above.
A summary of model parameters to estimate in this analysis is provided in Table
4.1. In order to compare how well M1 and M2 fit the data, we calculate the Akaike
information criterion (AIC), defined as 2p − 2 log(L̂), where p is the number of
parameters in the model and L̂ is the value of the likelihood function evaluated at
the maximum likelihood estimate. The AIC is used to quantify the goodness of
fit of a model to the data while penalizing models that contain a larger number
of parameters. The AIC can be used to compare models that are not nested, i.e.
models that are not contained within each other. A lower AIC usually indicates
a better fit to the data. All statistical analyses are conducted in the R version
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4.1.1 (2021-08-10) [91] software environment, and maximization of the likelihood
estimation is carried through unconstrained optimization using PORT routines as
implemented in the “nlminb” function in R. The full reproducible code is available
on GitHub (see ‘Availability of data and material’.
Table 4.1: Model specification for the analysis
model equations age-dependency threshold parameters to estimate
M1 (4.1), (4.8), (4.9), (4.10), (4.7) No Yes δ, σ2S− , σ2S+ , β0, β̃0, λ
M2 (4.3), (4.8), (4.9), (4.10), (4.7) Yes No δ, σ2S− , σ2S+ , β0, β1, β2, β̃0, β̃1, λ
Results
A comparison of AIC in Table 4.2 shows a lower value for M2 than M1 for both anti-
gens (29669.940 versus 33354.100 for Pf AMA1, and 31162.920 versus 31886.310
for Pf MSP119), indicating that the age-dependent mixture model in M2 is a better
fit to the data compared to M1, which assumes a single mixture distribution across
all ages. This age dependency is illustrated in Figures 4.5 and 4.6, which show an
increase in mean antibody levels and the mixture distribution with age. Of note,
the increase is much more prominent for Pf AMA1, than for Pf MSP119.
Additionally, in both M1 and M2, the separation between the two components
of the mixture distribution is more prominent in Pf AMA1 (Figure 4.5) than in
Pf MSP119 (Figure 4.6) where there is poor separation of the S+ and S− distribu-
tions. In the M2 Pf AMA1 analysis, the bi-modal distribution is more pronounced
between the ages of 5 to 10 years, and less so in younger and older individuals.
Figures 4.5 and 4.6 also indicate that age modulates the seropositivity threshold.
Figure 4.7 shows the difference in seroprevalence estimation between M1 and M2,
with overall higher estimates across age in the latter model. For both antigens, we
observe that the uncertainty resulting from M2, as quantified by the 95% confi-
dence intervals (CIs), in the seroprevalence estimates of the RCM is considerably
larger than M1. This is because the M2 estimates are obtained by incorporating
the uncertainty in the seropositivity classification, while M1 ignores this uncer-
tainty, resulting in very narrow confidence intervals for M1.
Figure 4.7 also shows that the RCM fitted using M2, provide a good interpolation
of the seroprevalence for Pf MSP119 but less so for the Pf AMA1. Although most of
the seroprevalence points fall within the 95% confidence interval, it is evident that,
as we approach 15 years of age, where the observed seroprevalence is not contained
within the 95% intervals, the model underestimates seroprevalence. This is made
more clear by visualizing the the y-axis of the plot in Figure 4.7 on the logit-scale
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Table 4.2: Maximum likelihood estimates with associated 95% CIs (within brackets)
for M1 and M2, fitted to Pf AMA1 and Pf MSP119 antibody data. The Akaike
Information Criterion (AIC) is also reported for the mixture models.
parameter M1 M2
Pf AMA1 Mixture Model
β0 -2.338 (-2.428, -2.249) -3.164 (-3.217, -3.111)
β1 0.052 (0.045, 0.058)
β2 -0.037 (-0.052, -0.023)
β̃0 -0.565 (-0.671, -0.460) -2.085 (-2.281, -1.890)
β̃1 0.401 (0.371, 0.432)
δ 11.706 (10.778, 12.722) 30.613 (26.224, 35.764)
σ2S− 0.014 (0.011, 0.019) 1.665 · 10−3 (1.383 · 10−3, 2.003 · 10−3)
σ2S+ 0.884 (0.716, 1.092) 43.521 (25.898, 73.138)
AIC 33354.100 29669.940
RCM λ 0.022 (0.020, 0.023) 0.175 (0.109, 0.286)
Pf MSP119
Mixture model
β0 -2.165 (-2.2656, -2.064) -2.915 (-2.989, -2.841)
β1 0.031 (0.028, 0.034)
β̃0 -1.220 (-1.429, -1.010) 0.081 (-0.114, 0.277)
β̃1 0.038 (0.022, 0.054)
δ 9.256 (8.624, 9.941) 11.698 (10.385, 13.193)
σ2S− 0.021 (0.015, 0.028) 2.770 · 10−3 (2.081 · 10−3, 3.687 · 10−3)
σ2S+ 0.994 (0.735, 1.346) 5.340 (3.387, 8.420)
AIC 31886.310 31162.920
RCM λ 0.060 (0.055, 0.066) 1.459 (0.760, 2.675)
Figure 4.4: Mixture distributions of Pf AMA1 and Pf MSP119 antibodies for
individuals between ages 1 and 16 using M1. These mixture distributions are derived
from equation (4.1), and all the data of individuals aged 1-16 are analysed together.
The red dotted lines illustrate the seropositivity thresholds (µS− + 3σS−), above which
individuals are be classified as S+ in traditional analysis.
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Figure 4.5: Age-dependent mixture distributions of Pf AMA1 antibodies for
individuals between ages 1 and 16 using M2. The blue line shows fitted distributions
derived from equations (4.3), (4.8) and (4.10). The red dotted lines illustrate the
seropositivity thresholds (µS− + 3σS−), above which individuals would be classified as
S+ in M1. Note that the red dotted lines are for illustration only - M2 does not use
thresholds
(see supplementary Figure S3). This indicates that, in the case of Pf AMA1, the
assumptions of the standard RCM may not be fully supported by the data, which
is undetected by the standard threshold-based model M1.
The distributions of λ estimates derived from M2 for both antigens are shown
in Figure 4.8. For Pf AMA1, λ is 0.175 (0.109, 0.286), while for Pf MSP119, this
is 1.459 (0.760, 2.675). Note that these estimates represent the mean, 2.5% and
97.5% quantiles from the Monte Carlo distributions of the maximum likelihood
estimates for λ.
Finally, supplementary Figures S4 and S5 show that M2 is consistent in the estima-
tion of both seroprevalence and λ, even when different age groups are considered
in analysis, unlike M1. Figure S6 also shows the additional variation in seropreva-
lence estimates for M1 when different seropositivity thresholds are used. Note
the marked decrease in seroprevalence estimates as the threshold increases (see
supplementary material).
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Figure 4.6: Age-dependent mixture distributions of Pf MSP119 antibodies for
individuals between ages 1 and 16 using M2. The blue line shows fitted distributions
derived from equations (4.3), (4.9) and (4.10). The red dotted lines show the
seropositivity thresholds (µS− + 3σS−), above which individuals would be classified as
S+ in M1. Note that the red dotted lines are for illustration only - M2 does not use
thresholds
Figure 4.7: Pf AMA1 and Pf MSP119 seroprevalence estimates from M1, and
seroprevalence distributions from M2, for individuals between ages 1 and 16. The top
row shows M1 seroprevalence point estimates (blue dots), as well as the fitted
seroprevalence curve (purple curve) and 95% CIs (purple dotted curves) from the
RCM. The bottom row shows the mean of the seroprevalence distribution derived from
M2 (blue dots), as well as the fitted seroprevalence curve (purple curve) and 95% CIs
(purple dotted curves) from the RCM.
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Figure 4.8: Distributions of the seroconversion rate λ derived from M2 for Pf AMA1
and Pf MSP119. The mean and 95% CIs for λ are indicated by blue and red dotted
lines respectively. For Pf AMA1, these are 0.175 (0.109, 0.286), while for Pf MSP119,
they are 1.459 (0.760, 2.675)
Discussion
In this paper we have presented a threshold-free method for estimating seropreva-
lence that incorporates the age dependency of malaria antibodies in the classi-
fication of individuals into seropositive and seronegative. Additionally, we have
demonstrated how the uncertainty of this classification can be accounted for in
a the RCM. We also point out that this approach can be applied to other types
of analyses that require the use of models different from the RCM. For example,
if the goal of the study is to map seroprevalence data within a study area, the
simulated classifications (previously denoted by Ci) could be used as the input of
a geostatistical model whose results are then summarized in a similar fashion as
presented for the RCM in this paper.
In the application of our modelling framework to the RCM, seroprevalence is mod-
elled into two different stages, using two different approaches: first, in a mixture
distribution, using a logit-linear regression; and secondly, in an RCM, using equa-
tion (4.7). This raises the question of a mathematical inconsistency since both
equations cannot be simultaneously true. We point out that this issue also applies
to previous work which uses threshold-based RCMs [25, 26, 34, 86], whereby the
threshold is first generated using a constant mixing probability, which would corre-
spond to an intercept-only logit-linear regression in our case, and is then modelled
using equation (4.7). To avoid this issue, one solution would be to replace the logit-
linear regression on age for seroprevalence, with equation (4.7), hence embedding
the assumptions of the RCM directly into the mixture distribution. However, our
preference remains with the approach illustrated in this paper for the following
reasons. First, the use of a logit-linear regression on age in the mixture distri-
butions allows us to develop an empirical approach that is more flexible than an
RCM and can better capture the variations of the antibody distributions across
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age. Secondly, the use of the RCM-based equation (4.7) for seroprevalence also in
the mixture distributions would yield a circular argument, whereby the outcome
to be modelled with the RCM would be already generated under an RCM, thus
making any validation of the RCM assumptions a vain exercise. As shown in our
case-study with western Kenya data, our approach can in fact better detect the
inadequacy of the RCM than the current threshold-based approach.
The results in this paper show clear age-dependency in the mean antibody levels,
the mixture distribution, and the threshold. The differences between Pf AMA1
and Pf MSP119 indicate that the magnitude of this dependency is likely dependent
on the type of antigen and the dynamics of the immune response to it. Notably,
results provide evidence that different combinations of age-groups in analysis lead
to different seropositivity thresholds and, therefore different seroprevalence esti-
mates. This inconsistency has significant implications for control programs which
rely on these results to direct intervention strategies. A key advantage of the
threshold-free approach is that it is unaffected by the age limits considered for the
analysis.
Furthermore, different definitions of the seropositivity threshold (i.e. between 2
and 5 standard deviations of the mean of the seronegative distribution) are an
additional source of inconsistency in current literature. This makes the compara-
bility of results reported across malaria serology studies more difficult. Avoiding
the use of an arbitrary threshold, as described in this paper, provides a statistically
rigorous solution to this problem and facilitates the comparison of results across
studies.
The limitations of dichotomizing continuous measurements into positive and nega-
tive for statistical analysis are well established in the literature, and include loss of
information which affects the ability to reliably recover regression relationships, as
well as reducing the the precision of parameter estimates [3–5]. However when the
scientific interest is in estimating seroprevalence - as we set out to do in this paper
- rather than modeling the dynamics that affect mean antibody antibody levels, di-
chotomization may be appropriate. This is because the approach presented in this
paper results in a more parsimonious model than the unified mechanistic model
presented in Kyomuhangi et al. [85], allowing for a more efficient estimation of
parameters that only modulate seroprevalence.
Depending on the degree of overlap between the seronegative and seropositive pop-
ulations in the sample, mixture models can be difficult to estimate. The Pf MSP119
analysis illustrates this key limitation. Due to the poor separation of the seroneg-
ative and seropositive populations, the estimate for λ shows a large value, which is
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inconsistent with both epidemiological data from the study site. This poor sepa-
ration could be a biological feature of the antibody response to Pf MSP119, or due
to poor dynamic range of the serological assay that generated the data. Similarly,
in areas of high transmission where the majority of the population is seropositive
[21, 40], or in elimination settings where there are very few seropositive cases,
estimating the model parameters may be difficult. In these scenarios, if prior
knowledge on some of the components of the model is available, Bayesian methods
of inference can be used to alleviate estimation issues though the specification of
suitable prior distributions. Additionally, to deal with skewness of the antibody
distributions which can still persists after taking the logarithmic transformation, a
mixture of skew-Normal distributions can be used in the mixture model to model
the left asymmetry of the seropositive population.
When fitting the RCM, the seroreversion rate may also be difficult to estimate,
hence ω is usually fixed [20]. In this paper, we considered the simplest form
of the RCM, which assumes constant transmission and ignores possible changes
in transmission due to, for example interventions in the recent past. While the
resulting seroprevalence curves from the RCM do not fit the data very well in
Figure 4.7, the majority of seroprevalence points fall within the 95% CIs of the
seroprevalence curves. Several studies have proposed modifications which relax
this assumption of constant transmission [20, 34, 42, 66], and each of these can be
fitted by using the Monte Carlo approach proposed in this paper to propagate the
uncertainty in the classification of seropositive individuals.
Conclusion
We have proposed a new threshold-free method for estimating malaria seropreva-
lence which accounts for age dependency of antibodies through regression, and
incorporates uncertainty around the estimates in subsequent analysis of the data.
This method is more robust to varying conditions of analysis and provides more
consistent estimates than the traditional threshold-based approach.
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Future work and conclusions
Each of the three papers presented in this thesis contains a detailed discussion,
therefore this chapter focuses on potential implications of the findings on future
research, and how these analyses can be expanded.
5.1 Paper 1
In paper 1 we conduct a comparative analysis between geostatistical models which
use continuous measurements of disease outcomes (i.e. a linear model), versus
those which use dichotomized data (i.e. a binomial model model), and measure
their performance in both parameter estimation and prediction of disease risk.
The results, which show how dichotomization leads to loss of information and
reduced predictive performance of geostatistical models, are in alignment with
similar comparisons in other fields of research. The practice of dichotomizing data
in disease mapping has potential ramifications for public health policy decisions.
For instance, where intervention strategies are developed based on exceedence
probabilities, greater uncertainty around estimates can translate into ineffective
public health and intervention policy.
Further comparative analysis on the performance of linear vs binomial geostatis-
tical models could be conducted by looking at different performance measures,
for example sensitivity and specificity in detecting hotspots, or considering other
categorizations of continuous data (i.e. multiple categories, rather than simply
positive/negative).
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5.2 Paper 2
In paper 2, we explore malaria serology models, where the prevailing method for
analysing serology data depends on dichotomization of continuous antibody mea-
surements. We propose a novel unified mechanistic model which 1) eliminates
the need to dichotomize continuous antibody measurements into seropositive and
seronegative data, 2) relaxes assumptions about malaria transmission dynamics,
3) adds flexibility in how transmission intensity can be estimated using regression
analysis, 4) incorporates age-dependency of the antibody distribution, and 5) al-
lows for joint estimation of malaria transmission intensity from both the reversible
catalytic and antibody acquisition models.
While the unified mechanistic model relaxes assumptions on the temporal dynam-
ics of λ(a) and γ(a), the model still assumes a monotone change in these transmis-
sion parameters, which may not capture all the variation these parameters over
time. In order to go beyond the assumption of monotonicity, longitudinal data is
required. This would likely be more reliable than cross-sectional data which, in
this context, can only be analysed under certain assumptions.
Of note, results from an additional analysis of another antigen, Pf MSP119 showed
limited indication of a bi-modal distribution and age-dependency, making estima-
tion of parameters from the unified mechanistic model unfeasible. Application of
the model to a wider range of anti-malaria antibodies could clarify which of the
many antigens currently under investigation would be more useful than others in
estimation of transmission parameters using this model.
Additionally, the results from this analysis indicated that a unified mechanistic
model that assumes a time-varying λ(a) and a constant γ provides a better fit to
the data than a model where the reverse assumptions is made, suggesting that
λ(a) may be a more suitable measure for surveillance purposes when the focus of
analysis is historical changes in transmission.
The unified mechanistic model provides opportunity to estimate both λ(a) and
γ(a), therefore the choice of metric could be informed by the properties of the
antibody response and distribution. This is particularly significant as further re-
search emerges about which specific antibodies correlate with protection, and as
multiplex immunoassays, which facilitate the analysis of multiple antigens simul-
taneously, become more common.
Other studies have described the study area as having low but highly heterogeneous
transmission [72, 73], and while the heterogeneity of transmission in this area is
not assessed in paper 2, the flexibility of the unified mechanistic model allows for
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an extension incorporating geostatistical analysis. This would make it suitable for
analysis of spatial variation in transmission intensity.
Results from the paper 2 analysis indicate a reduction in λ(a) over time, which is
consistent with previous findings for this study site [72, 73]. Explanation for why
transmission may have increased would require knowledge of additional factors
such presence and coverage of interventions, climate, as well as mosquito habi-
tat, characteristics and behaviour, among others. Nevertheless, the advantage of
the unified mechanistic model is that it provides flexibility to detect increases or
decreases in transmission, unlike current models which are bound by more rigid
assumptions on transmission profiles. Serology models alone can not explain why
changes have occurred, but rather, they provide important information on how
transmission parameters change over time. The unified mechanistic model im-
proves on how we derive this information from serology data.
5.3 Paper 3
In paper 3 we utilize the principles of the empirical model to estimate seropreva-
lence without thresholds. While the goal of most serology models, including the
unified mechanistic model, is to investigate historical changes in transmission,
seroprevalence itself gives us a snapshot of malaria exposure at a given time and
location.
The threshold-free approach proposed in paper 3 provides three key solutions in
seroprevalence estimation: it accounts for the age dependency of malaria antibod-
ies; allows us to propagate the uncertainty around classification of individuals as
seropositive and seronegative; and avoids the use of any threshold.
Given the age-dependency evidenced in both papers 2 and 3, additional consider-
ation of the age distribution of sample populations may be needed when designing
future studies. For example, many of the study areas included in this thesis have
a left skewed age distribution where younger individuals are much more prevalent
than older individuals in the sample. Depending on the goal of analysis, this should
be taken into account in the study design when recruiting study participants.
An application of this threshold-free approach in malaria research would be map-
ping of seroprevalence using geostatistical methods, where there is an urgent need
to identify hot-spots of disease burden [73] using a variety of malaria indicators,
particularly in places of low or highly heterogeneous transmission.
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5.4 Conclusion
In this thesis, we set out to explore the impact of thresholds and dichotomization on
statistical inference, with the aim of developing methods that improve estimation
and prediction of disease prevalence and risk.
The studies presented in this thesis demonstrate the significant impact using
thresholds and dichotomization of continuous health outcome data can have on
statistical inference. We show how dichotomization leads to loss of information,
reduces the reliability of parameter estimates, and reduces the predictive perfor-
mance of geostatistical models. We also demonstrate how the use of thresholds in
malaria serology models reduces the reliability of seroprevalence estimates.
Importantly, we present alternative statistical models which make full use of the
continuous health outcome measurements, rather than dichotomize the data. In
geostatistical analysis, we demonstrate the advantage of using a linear geostatis-
tical model compared to a binomial geostatistical model. For malaria serology
analysis, we develop a unified modelling framework which uses continuous anti-
body measurements and combines existing models while addressing their current
limitations.
Acknowledging that in some cases where dichotomization of data is necessary and
appropriate, for instance when the scientific interest is in estimating malaria sero-
prevalence, we propose a novel threshold-free approach for estimating seropreva-
lence.
Finally, in this thesis we present models for analysing continuous stunting, anaemia,
and malaria serology data, however the statistical principles underpinning these
proposed approaches can be applied to a variety of diseases, in order to develop
models which use continuous measurements of the disease indicator.
When developing these models, consideration should be given to key questions
including the research context, model complexity and computational intensity of
the new methods. For example, in cases where the disease outcome is determined
by presence or absence of an indicator rather than the scale of the continuous
measurement for the indicator, dichotomization of this data into positive and neg-
ative would not lead to any loss of information. In this context a model using
continuous measurements would not be suitable. Additionally, in the case of the
unified mechanistic model proposed in paper 2, the complexity of this model neces-
sitates a large data-set and advanced computational capacity in order to estimate
parameters reliably. This reduces the applicability of this method, particularly in
resource-limited settings where this analysis is most relevant.
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Together, the studies presented in this thesis strongly support the conclusion that,
whenever feasible, dichotomization should be avoided by developing models for the
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S.1 Paper 1 Supplementary material
S.1.1 Simulation study results for sample size m=450
Table S1: Bias and mean square error (in brackets) for α̃, σ̃2 and the estimate φ̂
obtained from the geostatistical models fitted the binary (B) and continuous (C)
outcomes. The following are results when the number of observations, n = 450
c=0 c=0.2 c=0.4
Parameter τ 2 φ B C B C B C
α̃ 0.5 0.1 -0.013 (0.090) -0.014 (0.056) 0.089 (0.216) 0.017 (0.068) 0.173 (0.180) 0.045 (0.085)
1 0.1 -0.007 (0.06) 0.001 (0.032) 0.081 (0.325) 0.019 (0.039) 0.159 (0.054) 0.034 (0.040)
2 0.1 -0.009 (0.031) -0.004 (0.017) 0.073 (0.448) 0.021 (0.019) 0.120 (0.128) 0.027 (0.022)
0.5 0.2 -0.030 (0.292) -0.029 (0.151) 0.100 (0.382) 0.013 (0.151) 0.228 (0.417) 0.023 (0.162)
1 0.2 -0.014 (0.169) -0.012 (0.077) 0.093 (0.401) 0.008 (0.071) 0.175 (0.167) 0.009 (0.079)
2 0.2 -0.006 (0.093) -0.001 (0.040) 0.079 (0.497) 0.011 (0.041) 0.156 (0.169) 0.015 (0.040)
σ̃2 0.5 0.1 0.603 (0.554) 0.735 (4.688) 0.624 (0.579) 0.747 (4.983) 0.570 (0.508) 0.780 (4.932)
1 0.1 0.289 (0.137) 0.543 (3.119) 0.297 (0.136) 0.679 (3.828) 0.274 (0.122) 0.508 (3.276)
2 0.1 0.125 (0.029) 0.417 (2.781) 0.112 (0.027) 0.462 (2.806) 0.107 (0.026) 0.446 (2.966)
0.5 0.2 1.096 (2.059) 0.289 (1.197) 1.120 (2.086) 0.387 (1.408) 1.078 (2.015) 0.230 (1.055)
1 0.2 0.566 (0.548) 0.131 (0.334) 0.565 (0.559) 0.133 (0.267) 0.533 (0.498) 0.105 (0.218)
2 0.2 0.252 (0.126) 0.100 (0.519) 0.243 (0.119) 0.116 (0.471) 0.228 (0.114) 0.075 (0.157)
φ 0.5 0.1 0.031 (0.002) 0.001 (0.001) 0.033 (0.002) 0.002 (0.001) 0.031 (0.002) 0.001 (0.001)
1 0.1 0.031 (0.002) 0.001 (0.002) 0.032 (0.002) -0.002 (0.001) 0.03 (0.002) 0.001 (0.002)
2 0.1 0.028 (0.002) 0.002 (0.002) 0.026 (0.002) 0.001 (0.002) 0.024 (0.002) 0.001 (0.003)
0.5 0.2 0.088 (0.018) -0.017 (0.004) 0.087 (0.017) -0.017 (0.005) 0.088 (0.018) -0.011 (0.005)
1 0.2 0.095 (0.021) -0.012 (0.007) 0.093 (0.019) -0.014 (0.006) 0.090 (0.018) -0.014 (0.006)
2 0.2 0.088 (0.020) -0.011 (0.010) 0.083 (0.018) -0.015 (0.009) 0.078 (0.017) -0.016 (0.009)
Table S2: Bias and mean square error (in brackets), averaged over a 1/14 by 1/14
regular grid in [0, 2]× [0, 1] (hence, m = 450), for the spatial predictions of prevalence
obtained from the geostatistical models fitted to the binary (B) and continuous (C)
outcomes.
c=0 c=0.2 c=0.4
τ 2 φ B C B C B C
0.5 0.1 0.001 (0.053) 0.001 (0.038) 0.013 (0.053) 0.001 (0.037) 0.029 (0.051) 0.001 (0.036)
1 0.1 -0.001 (0.047) 0.001 (0.037) 0.019 (0.047) -0.001 (0.037) 0.034 (0.046) -0.001 (0.035)
2 0.1 -0.002 (0.037) -0.001 (0.032) 0.020 (0.037) 0.001 (0.032) 0.037 (0.036) -0.001 (0.031)
0.5 0.2 -0.001 (0.041) 0.001 (0.029) 0.012 (0.041) 0.001 (0.029) 0.026 (0.039) -0.001 (0.027)
1 0.2 0.001 (0.036) 0.001 (0.027) 0.017 (0.036) -0.001 (0.027) 0.032 (0.035) -0.001 (0.025)
2 0.200 -0.001 (0.029) 0.001 (0.022) 0.020 (0.029) -0.001 (0.022) 0.037 (0.029) -0.001 (0.021)
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S.2 Paper 2 Supplementary material
S.2.1 Additional illustration of the mechanisms underlying the unified
mechanistic model
Contribution of individuals of different ages to the estimation of trans-
mission parameters λ and γ
Figure S1: An illustration of how individuals of different ages contribute to
estimation of λ and γ for Pf AMA1 through historical time. Data is taken from section
3.4. a− h and h, as defined by equation 3.11, represent X-years ago, and the age of the
individual X-years ago, respectively. For example in the top right panel, all individuals
above 1 year will contribute to the estimation of γ one year ago, however in the bottom
right panel, only individuals above 10 years will contribute to the estimation of γ 10
years ago. Note that individuals who contribute to the estimation of γ do so equally,
regardless of how old they were at the time, i.e. regardless of the value of h. Also note
that the further back in time we estimate γ, the fewer the number individuals, n,
contribute to the estimate.
Model formulations for the unified mechanistic model
Time discretization of the RCM
Let p(a) be the proportion of seropositive (S+) individuals at age a. Given that
individuals seroconvert from seronegative S− to S+ at rate λ(a), and serorevert
from S+ to S− at rate ω, the standard expression of the temporal dynamics in the
RCM:
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dp
da
= λ(a)(1− p(a))− ωp(a)
We then approximate this as
dp
da
≈ p(a)− p(a− 1)
Therefore,
p(a)− p(a− 1) = λ(a)(1− p(a))− ω(a)
p(a)− p(a− 1) = λ(a)− (λ(a)p(a))− ωp(a)
p(a) + (λ(a)p(a)) + ωp(a) = λ(a) + p(a− 1)
p(a)(1 + ω + λ(a)) = λ(a) + p(a− 1)
p(a) = 11 + ω + λ(a)(λ(a) + p(a− 1))
Assuming λ(0) = 0,
it follows that p(0) = 0
It then follows that,
p(1) = 11 + ω + λ1
(λ1 + 0)
= λ11 + ω + λ1




1 + ω + λ1)
)















k=h(1 + λ(h− k) + ω)
Time discretization of the AAM
Let µ(a) be geometric mean antibody level of individuals at age a. Assuming
anti-malaria antibodies of individuals are boosted at rate γ(a) upon exposure, and
decay at rate r in the absence of exposure, the standard expression of the temporal
dynamics in the AAM:
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We then apply the approximation
dµ
da
≈ µa − µa−1
which leads to







Assuming γ(0) = 0, we have µ(0) = 0
It then follows that,
µ(1) = 11 + rγ
µ(2) = 11 + r
(
γ + ( 11 + rγ1)
)





































S.2.2 Implementation of the unified mechanistic model in Section 3.4
Akaike Information Criterion (AIC) comparisons for the implementa-
tion of the unified mechanistic model
Table S3: Preliminary analysis of Western Kenya data, comparing the AIC for the
empirical model (EM) and unified mechanistic models (UFM) with time-varying λ &
constant γ, constant λ & time-varying γ, and different values of ω.
Model ω AIC
EM − 29711.460
UFM, constant λ, time-varying γ Continuous 30166.680
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S.3 Paper 3 Supplementary material
S.3.1 Profile likelihood for different values of ω
Figure S2: Profile likelihood analysis for different values of ω in the Pf AMA1 and
Pf MSP119 analyses
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S.3.2 Logit-transformed prevalence estimates from M2
Figure S3: Logit-transformed prevalence estimates from M2. The mean of the
seroprevalence distribution is indicated by blue dots; the purple solid and dotted curves
represent the fitted seroprevalence and 95% CIs, respectively, from the RCM; and the
orange line indicates the fitted seroprevalence estimate from the age-dependent
mixture model, as defined by equation (10)
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S.3.3 M1 and M2 analysis using data from different age groups
Figure S4: Analysis of Pf AMA1 mixture distributions using different age-groups in
both M1 and M2. The mixture distributions in the top row are derived from M1 (see
equation (1)), and show the seropositivity thresholds (red dotted lines represent
µS− + 3σS−) when different age groups are used in analysis. The middle row shows M1
seroprevalence point estimates (blue dots), as well as the fitted seroprevalence curve
(purple curve) and 95% CIs (purple dotted curves) from the RCM. The bottom row
shows the mean of the seroprevalence distribution derived from M2 (blue dots), as well
as the fitted seroprevalence curve (purple curve) and 95% CIs (purple dotted curves)
from the RCM.
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Figure S5: Analysis of Pf MSP119 mixture distributions using different age-groups in
both M1 and M2. The mixture distributions in the top row are derived from M1 (see
equation (1)), and show the seropositivity thresholds (red dotted lines represent
µS− + 3σS− thresholds) when different age groups are used in analysis. The middle row
shows M1 seroprevalence estimates (blue dots), as well as the fitted seroprevalence
curve (purple curve) and 95% CIs (purple dotted curves) from the RCM. The bottom
row shows the mean of the seroprevalence distribution derived from M2 (blue dots), as
well as the fitted seroprevalence curve (purple curve) and 95% CIs (purple dotted
curves) from the RCM.
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S.3.4 M1 analysis using different seropositivity thresholds for individ-
uals aged 1-16 years
Figure S6: The top row shows M1 seroprevalence point estimates (blue dots) where
seropositivity is defined as µS− + 2σS− , as well as the fitted seroprevalence curve
(purple curve) and 95% CIs (purple dotted curves) from the RCM. The middle row
shows where seropositivity is defined as µS− + 3σS− , and the bottom row shows where
seropositivity is defined as µS− + 4σS−
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